Section 11

EurekaMag PDF full texts Chapter 10,947


Zheng, B.; Fiumara, P.; Li, Y.V.; Georgakis, G.; Snell, V.; Younes, M.; Vauthey, J.N.; Carbone, A.; Younes, A. 2003: MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. Blood 102(3): 1019-1027
Samarakoon, R.; Higgins, P.J. 2002: MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks. Journal of Cell Science 115(Part 15): 3093-3103
Boucher, M.J.; Morisset, J.; Vachon, P.H.; Reed, J.C.; Lainé, J.; Rivard, N. 2000: MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. Journal of Cellular Biochemistry 79(3): 355-369
Ding, X.Z.; Adrian, T.E. 2001: MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1. Biochemical and Biophysical Research Communications 282(2): 447-453
Wilson, D.J.; Alessandrini, A.; Budd, R.C. 1999: MEK1 activation rescues Jurkat T cells from Fas-induced apoptosis. Cellular Immunology 194(1): 67-77
Belka, C.; Knippers, P.; Rudner, J.; Faltin, H.; Bamberg, M.; Budach, W. 2000: MEK1 and Erk1/2 kinases as targets for the modulation of radiation responses. Anticancer Research 20(5a): 3243-3249
Pinkas, J.; Leder, P. 2002: MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Research 62(16): 4781-4790
Yu, C.; Wang, Z.; Dent, P.; Grant, S. 2001: MEK1/2 inhibitors promote Ara-C-induced apoptosis but not loss of Deltapsi(m) in HL-60 cells. Biochemical and Biophysical Research Communications 286(5): 1011-1018
Xiao, L.; Pimental, D.R.; Amin, J.K.; Singh, K.; Sawyer, D.B.; Colucci, W.S. 2001: MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. Journal of Molecular and Cellular Cardiology 33(4): 779-787
Diaz-Meco, M.T.; Moscat, J. 2001: MEK5, a new target of the atypical protein kinase C isoforms in mitogenic signaling. Molecular and Cellular Biology 21(4): 1218-1227
Dashti, S.R.; Efimova, T.; Eckert, R.L. 2001: MEK7-dependent activation of p38 MAP kinase in keratinocytes. Journal of Biological Chemistry 276(11): 8059-8063
Xu, X.; Stewart, J.T. 2000: MEKC determination of guaifenesin, pseudoephedrine, and dextromethorphan in a capsule dosage form. Journal of Liquid Chromatography and Related Technologies 23(1): 1-13
Viglio, S.; Iadarola, P.; Lupi, A.; Trisolini, R.; Tinelli, C.; Balbi, B.; Grassi, V.; Worlitzsch, D.; Döring, G.; Meloni, F.; Meyer, K.C.; Dowson, L.; Hill, S.L.; Stockley, R.A.; Luisetti, M. 2000: MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. European Respiratory Journal 15(6): 1039-1045
Brown, J.D.; DiChiara, M.R.; Anderson, K.R.; Gimbrone, M.A.; Topper, J.N. 1999: MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. Journal of Biological Chemistry 274(13): 8797-8805
Lee, H.; Jiang, F.; Wang, Q.; Nicosia, S.V.; Yang, J.; Su, B.; Bai, W. 2000: MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells. Molecular Endocrinology 14(11): 1882-1896
Karandikar, M.; Xu, S.; Cobb, M.H. 2000: MEKK1 binds raf-1 and the ERK2 cascade components. Journal of Biological Chemistry 275(51): 40120-40127
Komoda, F.; Shino, Y.; Hirano, T.; Okutomi, Y.; Okamoto, H.; Hayashi, Y.; Suyama, T.; Ebara, M.; Saisho, H.; Shirasawa, H. 2002: MEKK1 induces c-Jun complexes that act as negative regulators for cell survival and proliferation of HCC cells. International Journal of Oncology 21(3): 553-559
Christerson, L.B.; Vanderbilt, C.A.; Cobb, M.H. 1999: MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions. Cell Motility and the Cytoskeleton 43(3): 186-198
Kwan, R.; Burnside, J.; Kurosaki, T.; Cheng, G. 2001: MEKK1 is essential for DT40 cell apoptosis in response to microtubule disruption. Molecular and Cellular Biology 21(21): 7183-7190
Witowsky, J.; Abell, A.; Johnson, N.L.; Johnson, G.L.; Cuevas, B.D. 2003: MEKK1 is required for inducible urokinase-type plasminogen activator expression. Journal of Biological Chemistry 278(8): 5941-5946
Roy, S.K.; Hu, J.; Meng, Q.; Xia, Y.; Shapiro, P.S.; Reddy, S.P.M.; Platanias, L.C.; Lindner, D.J.; Johnson, P.F.; Pritchard, C.; Pagés, G.; Pouyssegur, J.; Kalvakolanu, D.V. 2002: MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma. Proceedings of the National Academy of Sciences of the United States of America 99(12): 7945-7950
Cuevas, B.D.; Abell, A.N.; Witowsky, J.A.; Yujiri, T.; Johnson, N.Lassignal.; Kesavan, K.; Ware, M.; Jones, P.L.; Weed, S.A.; DeBiasi, R.L.; Oka, Y.; Tyler, K.L.; Johnson, G.L. 2003: MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO Journal 22(13): 3346-3355
Sun, W.; Kesavan, K.; Schaefer, B.C.; Garrington, T.P.; Ware, M.; Johnson, N.L.; Gelfand, E.W.; Johnson, G.L. 2001: MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. Journal of Biological Chemistry 276(7): 5093-5100
Garrington, T.P.; Ishizuka, T.; Papst, P.J.; Chayama, K.; Webb, S.; Yujiri, T.; Sun, W.; Sather, S.; Russell, D.M.; Gibson, S.B.; Keller, G.; Gelfand, E.W.; Johnson, G.L. 2000: MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. EMBO Journal 19(20): 5387-5395
Su, B.; Cheng, J.; Yang, J.; Guo, Z. 2001: MEKK2 is required for T-cell receptor signals in JNK activation and interleukin-2 gene expression. Journal of Biological Chemistry 276(18): 14784-14790
Chao, T.H.; Hayashi, M.; Tapping, R.I.; Kato, Y.; Lee, J.D. 1999: MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. Journal of Biological Chemistry 274(51): 36035-36038
Kanungo, J.; Potapova, I.; Malbon, C.C.; Wang, H.y. 2000: MEKK4 mediates differentiation in response to retinoic acid via activation of c-Jun N-terminal kinase in rat embryonal carcinoma P19 cells. Journal of Biological Chemistry 275(31): 24032-24039
Tsuchiya, K.; Miyazaki, H.; Akabane, H.; Yamamoto, M.; Kondo, H.; Mizusawa, H.; Ikeda, K. 1999: MELAS with prominent white matter gliosis and atrophy of the cerebellar granular layer: A clinical, genetic, and pathological study. Acta Neuropathologica 97(5): 520-524
Tanahashi, C.; Nakayama, A.; Yoshida, M.; Ito, M.; Mori, N.; Hashizume, Y. 2000: MELAS with the mitochondrial DNA 3243 point mutation: A neuropathological study. Acta Neuropathologica 99(1): 31-38
Sparaco, M.; Simonati, A.; Cavallaro, T.; Bartolomei, L.; Grauso, M.; Piscioli, F.; Morelli, L.; Rizzuto, N. 2003: MELAS: clinical phenotype and morphological brain abnormalities. Acta Neuropathologica 106(3): 202-212
Gòdia, F.; Albiol, J.; Montesinos, J.L.; Pérez, J.; Creus, N.; Cabello, F.; Mengual, X.; Montras, A.; Lasseur, C. 2002: MELISSA: A loop of interconnected bioreactors to develop life support in Space. Journal of Biotechnology 99(3): 319-330
Le Novère, N. 2001: MELTING, computing the melting temperature of nucleic acid duplex. Bioinformatics 17(12): 1226-1227
Huang, Y.; Mather, E.L.; Bell, J.L.; Madou, M. 2002: MEMS-based sample preparation for molecular diagnostics. Analytical and Bioanalytical Chemistry 372(1): 49-65
Ferrari, L.; Altamura, M.; De Luca, M.; Ceruti, T. 2002: MEN 10700, a new penem antibiotic: in vitro antibacterial activity on clinical isolates. ChemoTherapy 48(1): 15-20
Meini, S.; Quartara, L.; Rizzi, A.; Patacchini, R.; Cucchi, P.; Giolitti, A.; Calò, G.; Regoli, D.; Criscuoli, M.; Maggi, C.A. 1999: MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor. Journal of Pharmacology and Experimental Therapeutics 289(3): 1250-1256
Alfaro, J.J.; Lamas, C.; Estrada, J.; Lucas, T. 2002: MEN-2A syndrome and pulmonary metastasis. Postgraduate Medical Journal 78(915): 51-52
Cetani, F.; Pardi, E.; Vignali, E.; Borsari, S.; Picone, A.; Cianferotti, L.; Ambrogini, E.; Miccoli, P.; Pinchera, A.; Marcocci, C. 2002: MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism. Journal of Endocrinological Investigation 25(6): 508-512
Heppner, C.; Reincke, M.; Agarwal, S.K.; Mora, P.; Allolio, B.; Burns, A.L.; Spiegel, A.M.; Marx, S.J. 1999: MEN1 gene analysis in sporadic adrenocortical neoplasms. Journal of Clinical Endocrinology and Metabolism 84(1): 216-219
Morelli, A.; Falchetti, A.; Martineti, V.; Becherini, L.; Mark, M.; Friedman, E.; Brandi, M.L. 2000: MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. European Journal of Endocrinology 142(2): 131-137
Debelenko, L.V.; Swalwell, J.I.; Kelley, M.J.; Brambilla, E.; Manickam, P.; Baibakov, G.; Agarwal, S.K.; Spiegel, A.M.; Marx, S.J.; Chandrasekharappa, S.C.; Collins, F.S.; Travis, W.D.; Emmert-Buck, M.R. 2000: MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma. Genes Chromosomes and Cancer 28(1): 58-65
Görtz, B.; Roth, J.; Speel, E.J.; Krähenmann, A.; De Krijger, R.R.; Matias-Guiu, X.; Muletta-Feurer, S.; Rütmann, K.; Saremaslani, P.; Heitz, P.U.; Komminoth, P. 1999: MEN1 gene mutation analysis of sporadic adrenocortical lesions. International Journal of Cancer 80(3): 373-379
Bartsch, D.; Kopp, I.; Bergenfelz, A.; Rieder, H.; Münch, K.; Jäger, K.; Deiss, Y.; Schudy, A.; Barth, P.; Arnold, R.; Rothmund, M.; Simon, B. 1998: MEN1 gene mutations in 12 MEN1 families and their associated tumors. European Journal of Endocrinology 139(4): 416-420
Fujii, T.; Kawai, T.; Saito, K.; Hishima, T.; Hayashi, Y.; Imura, J.; Hironaka, M.; Hosoya, Y.; Koike, M.; Fukayama, M. 1999: MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation. Pathology International 49(11): 968-973
Livingstone, K.; Rieseberg, L. 2003: MENDB: a database of polymorphic loci from natural populations. Bioinformatics 19(5): 663-664
Grigoryev, S.A.; Bednar, J.; Woodcock, C.L. 1999: MENT, a heterochromatin protein that mediates higher order chromatin folding, is a new serpin family member. Journal of Biological Chemistry 274(9): 5626-5636
Alpy, F.; Wendling, C.; Rio, M.-C.; Tomasetto, C. 2002: MENTHO, a MLN64 homologue devoid of the START domain. Journal of Biological Chemistry 277(52): 50780-50787
Henrich, T.; Ramialison, M.; Quiring, R.; Wittbrodt, B.; Furutani-Seiki, M.; Wittbrodt, J.; Kondoh, H. 2003: MEPD: a Medaka gene expression pattern database. Nucleic Acids Research 31(1): 72-74
Rowe, P.S.; de Zoysa, P.A.; Dong, R.; Wang, H.R.; White, K.E.; Econs, M.J.; Oudet, C.L. 2000: MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67(1): 54-68
Argiro, L.; Desbarats, M.; Glorieux, F.H.; Ecarot, B. 2001: Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 74(3): 342-351
Doerffer, R.; Sorensen, K.; Aiken, J. 1999: MERIS potential for coastal zone applications. International Journal of Remote Sensing 20(9): 1809-1818
Bricaud, A.; Morel, A.; Barale, V. 1999: MERIS potential for ocean colour studies in the open ocean. International Journal of Remote Sensing 20(9): 1757-1769
Hjalmarson, A.; Fagerberg, B. 2000: MERIT-HF mortality and morbidity data. Basic Research in Cardiology 95(Suppl 1): I 98-I 103
Wikstrand, J. 2000: MERIT-HF: Description of the trial. Basic Research in Cardiology 95(Suppl 1): I 90-I 97
Gregorio-King, C.C.; McLeod, J.L.; Collier, F.McL.; Collier, G.R.; Bolton, K.A.; Van Der Meer, G.J.; Apostolopoulos, J.; Kirkland, M.A. 2002: MERP1: A mammalian ependymin-related protein gene differentially expressed in hematopoietic cells. Gene 286(2): 249-257
Berkowitz, L.A.; Strome, S. 2000: MES-1, a protein required for unequal divisions of the germline in early C. elegans embryos, resembles receptor tyrosine kinases and is localized to the boundary between the germline and gut cells. Development 127(20): 4419-4431
Carroll, K.M.; Farentinos, C.; Ball, S.A.; Crits-Christoph, P.; Libby, B.; Morgenstern, J.; Obert, J.L.; Polcin, D.; Woody, G.E. 2002: MET meets the real world: Design issues and clinical strategies in the Clinical Trials Network. Journal of Substance Abuse Treatment 23(2): 73-80
Ferracini, R.; Angelini, P.; Cagliero, E.; Linari, A.; Martano, M.; Wunder, J.; Buracco, P. 2000: MET oncogene aberrant expression in canine osteosarcoma. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 18(2): 253-256
Morello, S.; Olivero, M.; Aimetti, M.; Bernardi, M.; Berrone, S.; Di Renzo, M.F.; Giordano, S. 2001: MET receptor is overexpressed but not mutated in oral squamous cell carcinomas. Journal of Cellular Physiology 189(3): 285-290
Hayashi, Y.; Ishida, H.; Hoshiai, M.; Hoshiai, K.; Kirimoto, T.; Kanno, T.; Nakano, M.; Tajima, K.; Miyake, H.; Matsuura, N.; Nakazawa, H. 2000: MET-88, a gamma-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction. Molecular and Cellular Biochemistry 209(1-2): 39-46
Spiropoulos, A.; Bisson, L.F. 2000: MET17 and hydrogen sulfide formation in Saccharomyces cerevisiae. Applied and Environmental Microbiology 66(10): 4421-4426
Mao, X.; Hu, Y.; Liang, C.; Lu, C. 2002: MET3 promoter: a tightly regulated promoter and its application in construction of conditional lethal strain. Current Microbiology 45(1): 37-40
Sedykh, A.; Saiakhov, R.; Klopman, G. 2001: META V. A model of photodegradation for the prediction of photoproducts of chemicals under natural-like conditions. Chemosphere 45(6-7): 971-981
Eyrich, V.A.; Rost, B. 2003: META-PP: single interface to crucial prediction servers. Nucleic Acids Research 31(13): 3308-3310
Strand, A.E. 2002: METASIM 1.0: An individual-based environment for simulating population genetics of complex population dynamics. Molecular Ecology Notes 2(3): 373-376
Foster, E.K. 2003: METASTATS: Behavioral science statistics for microsoft Windows and the HP49G programmable calculator. Behavior Research Methods Instruments and Computers: a Journal of the Psychonomic Society Inc 35(2): 325-328
Pfeiffer, T.; Sánchez-Valdenebro, I.; Nuño, J.C.; Montero, F.; Schuster, S. 1999: METATOOL: For studying metabolic networks. Bioinformatics 15(3): 251-257
Vázquez, F.; Hastings, G.; Ortega, M.A.; Lane, T.F.; Oikemus, S.; Lombardo, M.; Iruela-Arispe, M.L. 1999: METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. Journal of Biological Chemistry 274(33): 23349-23357
Devine, G.J.; Khambay, B.P. 2001: METI-acaricide resistance in Tetranychus urticae does not confer resistance to the naphthoquinones. Pest Management Science 57(8): 749-750
Williams, T.A.; Longati, P.; Pugliese, L.; Gual, P.; Bardelli, A.; Michieli, P. 1999: MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential. Journal of Cellular Physiology 181(3): 507-514
Schubert, C.M.; Lin, R.; de Vries, C.J.; Plasterk, R.H.; Priess, J.R. 2000: MEX-5 and MEX-6 function to establish soma/germline asymmetry in early C. elegans embryos. Molecular Cell 5(4): 671-682
Szlinder-Richert, J.; Mazerski, J.; Cybulska, B.; Grzybowska, J.; Borowski, E. 2001: MFAME, N-methyl-N-D-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity: relationship between self-association and effects on red blood cells. Biochimica et Biophysica Acta 1528(1): 15-24
Matsuoka, S.; Saito, T.; Kuwayama, H.; Morita, N.; Ochiai, H.; Maeda, M. 2003: MFE1, a member of the peroxisomal hydroxyacyl coenzyme A dehydrogenase family, affects fatty acid metabolism necessary for morphogenesis in Dictyostelium spp. Eukaryotic Cell 2(3): 638-645
Yang, X.L.; Matsuura, H.; Fu, Y.; Sugiyama, T.; Miura, N. 2000: MFH-1 is required for bone morphogenetic protein-2-induced osteoblastic differentiation of C2C12 myoblasts. FEBS Letters 470(1): 29-34
Gagnon, M.-Monique; Holdway, D.-Alan 1998: MFO induction in Atlantic salmon (Salmo salar) during and after exposure to Bass Strait crude oil. Australasian Journal of Ecotoxicology 4(1): 29-35
Coakley, J.; Hodson, P.V.; Van Heiningen, A.; Cross, T. 2001: MFO induction in fish by filtrates from chlorine dioxide bleaching of wood pulp. Water Research 35(4): 921-928
Smith, B.J.; Gagnon, M.M. 2000: MFO induction of three Australian fish species. Environmental Toxicology 15(1): 1-7
Jeong, S.Yong.; Rose, A.; Meier, I. 2003: MFP1 is a thylakoid-associated, nucleoid-binding protein with a coiled-coil structure. Nucleic Acids Research 31(17): 5175-5185
Panerai, A.E.; Nicoletti, F.; Sacedote, P.; Arvidsson, L.; Conget, I.; Gomis, R.; Bartorelli, A.; Sandler, S. 2001: MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetologia 44(7): 839-847
Guo, D.; Dong, M.; Yuan, Y. 2002: MG7 expression in helicobacter pylori-related gastric diseases. Zhonghua Zhong Liu Za Zhi 24(2): 151-153
Dula, M.L.; Holmes, S.G. 2000: MGA2 and SPT23 are modifiers of transcriptional silencing in yeast. Genetics 156(3): 933-941
Jiang, Y.; Vasconcelles, M.J.; Wretzel, S.; Light, A.; Martin, C.E.; Goldberg, M.A. 2001: MGA2 is involved in the low-oxygen response element-dependent hypoxic induction of genes in Saccharomyces cerevisiae. Molecular and Cellular Biology 21(18): 6161-6169
Zhang, S.; Skalsky, Y.; Garfinkel, D.J. 1999: MGA2 or SPT23 is required for transcription of the delta9 fatty acid desaturase gene, OLE1, and nuclear membrane integrity in Saccharomyces cerevisiae. Genetics 151(2): 473-483
Katoh, M.; Katoh, M. 2003: MGC29506 gene, frequently down-regulated in intestinal-type gastric cancer, encodes secreted-type protein with conserved cysteine residues. International Journal of Oncology 23(1): 235-241
Katoh, M.; Katoh, M. 2003: MGC9753 gene, located within PPP1R1B-STARD3-ERBB2-GRB7 amplicon on human chromosome 17q12, encodes the seven-transmembrane receptor with extracellular six-cystein domain. International Journal of Oncology 22(6): 1369-1374
Blake, J.A.; Richardson, J.E.; Bult, C.J.; Kadin, J.A.; Eppig, J.T. 2003: MGD: the Mouse Genome Database. Nucleic Acids Research 31(1): 193-195
Kirches, E.; Scherlach, C.; von Bossanyi, P.; Schneider, T.; Szibor, R.; Kutz, E.; Warich-Kirches, M.; Dietzmann, K. 1999: MGMT- and P450 3A-inhibitors do not sensitize glioblastoma cell cultures against nitrosoureas. Clinical Neuropathology 18(1): 1-8
Wu, M.S.; Tani, K.; Sugiyama, H.; Hibino, H.; Izawa, K.; Tanabe, T.; Nakazaki, Y.; Ishii, H.; Ohashi, J.; Hohjoh, H.; Iseki, T.; Tojo, A.; Nakamura, Y.; Tanioka, Y.; Tokunaga, K.; Asano, S. 2000: MHC (Major histocompatibility complex)-DRB genes and polymorphisms in common marmoset. Journal of Molecular Evolution 51(3): 214-222
Sudomoina, M.A.; Boiko, A.N.; Spurkland, A.; Gusev, E.I.; Boldyreva, M.N.; Trofimov, D.Y.; Alekseev, L.P.; Favorova, O.O.; Vardal, F. 1999: MHC DPB1 gene polymorphism in patients with multiple sclerosis in Russian population. Immunologiya 5: 45-48
Deitz, S.B.; Dodd, D.A.; Cooper, S.; Parham, P.; Kirkegaard, K. 2000: MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proceedings of the National Academy of Sciences of the United States of America 97(25): 13790-13795
Wang, Z.; Turner, R.; Baker, B.M.; Biddison, W.E. 2002: MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors. Journal of Immunology 169(6): 3146-3154
Haller, G.W.; Lima, B.; Kunisaki, S.M.; Germana, S.; Leguern, C.; Huang, C.A.; Sachs, D.H. 2002: MHC alloantigens elicit secondary, but not primary, indirect in vitro proliferative responses. Journal of Immunology 169(7): 3613-3621
Akesson, E.; Markling, L.; Kjaeldgaard, A.; Falci, S.; Ringdén, O. 2000: MHC antigen expression in human first trimester spinal cord with implications for clinical transplantation procedures. Journal of Neuroimmunology 111(1-2): 210-214
Mühl, T.; Krawczak, M.; Ten Haaft, P.; Hunsmann, G.; Sauermann, U. 2002: MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. Journal of Immunology 169(6): 3438-3446
Papassavas, E.C.; Spyropoulou-Vlachou, M.; Papassavas, A.C.; Schipper, R.F.; Doxiadis, I.N.; Stavropoulos-Giokas, C. 2000: MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data. Human Immunology 61(6): 615-623
Garcia-Lora, A.; Algarra, I.; Garrido, F. 2003: MHC class i antigens, immune surveillance, and tumor immune escape. Journal of Cellular Physiology 195(3): 346-355
Lopez-Vazquez, A.; Rodrigo, L.; Fuentes, D.; Riestra, S.; Bousoño, C.; Garcia-Fernandez, S.; Martinez-Borra, J.; Gonzalez, S.; Lopez-Larrea, C. 2002: MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201. Gut 50(3): 336-340
Orchard, T.R.; Dhar, A.; Simmons, J.D.; Vaughan, R.; Welsh, K.I.; Jewell, D.P. 2001: MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy. Clinical and Experimental Immunology 126(3): 437-440
Fdez-Morera, J.Luis.; Rodrigo, L.; López-Vázquez, A.; Rodero, S.R.; Martínez-Borra, Jús.; Niño, P.; González, S.; López-Larrea, C. 2003: MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Human Immunology 64(8): 816-822
Ruhwald, M.; Pedersen, A.E.; Claesson, M.H. 1999: MHC class i cross-talk with CD2 and CD28 induces specific intracellular signalling and leads to growth retardation and apoptosis via a p56(lck)-dependent mechanism. Experimental and Clinical Immunogenetics 16(4): 199-211
Antao, A.B.; Chinchar, V.G.; McConnell, T.J.; Miller, N.W.; Clem, L.W.; Wilson, M.R. 1999: MHC class I genes of the channel catfish: sequence analysis and expression. Immunogenetics 49(4): 303-311
Flügge, P.; Fuchs, E.; Günther, E.; Walter, L. 2002: MHC class i genes of the tree shrew Tupaia belangeri. Immunogenetics 53(10-11): 984-988
Brouwenstijn, N.; Serwold, T.; Shastri, N. 2001: MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum. Immunity 15(1): 95-104
Wang, Z.Q.; Bapat, A.S.; Trejo, V.; Orlikowsky, T.; Mittler, R.S.; Hoffmann, M.K. 1999: MHC class i molecules on CD4 T cells regulate receptor-mediated activation signals. Cellular Immunology 193(1): 108-114
Routes, J.M.; Ryan, J.C.; Ryan, S.; Nakamura, M. 2001: MHC class i molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection. International Immunology 13(10): 1301-1307
Zia, A.; Schildberg, F.W.; Funke, I. 2001: MHC class I negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in R0M0 breast cancer patients. International Journal of Cancer 93(4): 566-570
Li, S.; Holdsworth, S.R.; Tipping, P.G. 2000: MHC class I pathway is not required for the development of crescentic glomerulonephritis in mice. Clinical and experimental immunology 122(3): 453-458
Khakoo, S.I.; Brooks, C.R. 2003: MHC class i receptors on natural killer cells: on with the old and in with the new. Clinical Science 105(2): 127-140
Natarajan, K.; Dimasi, N.; Wang, J.; Margulies, D.H.; Mariuzza, R.A. 2002: MHC class I recognition by Ly49 natural killer cell receptors. Molecular Immunology 38(14): 1023-1027
Finelli, A.; Kerksiek, K.M.; Allen, S.E.; Marshall, N.; Mercado, R.; Pilip, I.; Busch, D.H.; Pamer, E.G. 1999: MHC class i restricted T cell responses to Listeria monocytogenes, an intracellular bacterial pathogen. Immunologic Research 19(2-3): 211-223
Boname, J.M.; Stevenson, P.G. 2001: MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15(4): 627-636
Lobigs, M.; Müllbacher, A.; Regner, M. 2003: MHC class i up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogen. Immunology and Cell Biology 81(3): 217-223
Men, Y.; Audran, R.; Thomasin, C.; Eberl, G.; Demotz, S.; Merkle, H.P.; Gander, B.; Corradin, G. 1999: MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine 17(9-10): 1047-1056
Garcia-Lora, A.; Martinez, M.; Algarra, I.; Gaforio, J.J.; Garrido, F. 2003: MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components. International Journal of Cancer 106(4): 521-527
el-Shami, K.; Tirosh, B.; Bar-Haim, E.; Carmon, L.; Vadai, E.; Fridkin, M.; Feldman, M.; Eisenbach, L. 1999: MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope. European Journal of Immunology 29(10): 3295-3301
Benz, C.; Hengel, H. 2000: MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance. Virus Genes 21(1-2): 39-47
Xu, M.; Li, J.; Gulfo, J.V.; Von Hofe, E.; Humphreys, R.E. 2001: MHC class II allosteric site drugs: New immunotherapeutics for malignant, infectious and autoimmune diseases. Scandinavian Journal of Immunology 54(1-2): 39-44
Shimada, H.; Germana, S.; Sonntag, K.C.; Banerjee, P.; Moore, D.; Sachs, D.H.; LeGuern, C. 1999: MHC class Ii alpha/beta heterodimeric cell surface molecules expressed from a single proviral genome. Human Gene Therapy 10(14): 2397-2405
McLellan, A.; Heldmann, M.; Terbeck, G.; Weih, F.; Linden, C.; Bröcker, E.B.; Leverkus, M.; Kämpgen, E. 2000: MHC class Ii and CD40 play opposing roles in dendritic cell survival. European Journal of Immunology 30(9): 2612-2619
Ody, C.; Corbel, C.; Dunon, D.; Vainio, O.; Imhof, B.A. 2000: MHC class Ii and c-kit expression allows rapid enrichment of T-cell progenitors from total bone marrow cells. Blood 96(12): 3988-3990
Engering, A.J.; Richters, C.D.; Fluitsma, D.M.; van Pelt, A.M.; Kamperdijk, E.W.; Hoefsmit, E.C.; Pieters, J. 1998: MHC class II and invariant chain biosynthesis and transport during maturation of human precursor dendritic cells. International Immunology 10(11): 1713-1723
Deeg, H.J.; Lesnikov, V. 1998: MHC class II and negative regulators of hematopoiesis. Archivum Immunologiae et Therapiae Experimentalis 46(5): 285-291
Tokuda, N.; Katsube, K.; Sakuragi, A.; Nagato, S.; Harada, D.; Arudchelvan, Y.; Mizutani, N.; Wang, Y.-Hsueh; Sawada, T.; Fujikura, Y.; Fukumoto, T. 2002: MHC class II antigen expression was different from MHC class I antigen expression in irradiated and recovering rat thymus. Acta Histochemica et Cytochemica 35(2): 101-105
Walter, W.; Lingnau, K.; Schmitt, E.; Loos, M.; Maeurer, M.J. 2000: MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?. British Journal of Cancer 83(9): 1192-1201
Lehner, M.; Stöckl, J.; Majdic, O.; Knapp, W.; Hüttner, K.; Felzmann, T.; Holter, W. 2003: MHC class II antigen signaling induces homotypic and heterotypic cluster formation of human mature monocyte derived dendritic cells in the absence of cell death. Human Immunology 64(8): 762-770
Rands, A.L.; Whyte, J.; Cox, B.; Hall, N.D.; McHugh, N.J. 2000: MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I. Journal of Autoimmunity 15(4): 451-458
Ody, C.; Corbel, C.; Dunon, D.; Vainio, O.; A Imhof, B. 2001: MHC class Ii beta-chain and alphaIIbbeta3 integrin are expressed on T-cell progenitors in embryonic bone marrow. Molecular Immunology 38(1): 45-53
Buisson, S.; Triebel, Fédéric. 2003: MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells. Vaccine 21(9-10): 862-868
Kim, M.Kyung.; Choi, Y-La.; Kim, M.Kyung.; Kim, S-Hyung.; Choi, E.Young.; Park, W.Seo.; Bae, Y.Mee.; Woo, S.Kyu.; Park, S.Hoe. 2003: MHC class II engagement inhibits CD99-induced apoptosis and up-regulation of T cell receptor and MHC molecules in human thymocytes and T cell line. FEBS Letters 546(2-3): 379-384
Jabrane-Ferrat, N.; Nekrep, N.; Tosi, G.; Esserman, L.; Peterlin, B.Matija. 2003: MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?. International Immunology 15(4): 467-475
Wallace, P.K.; Yeaman, G.R.; Johnson, K.; Collins, J.E.; Guyre, P.M.; Wira, C.R. 2001: MHC class II expression and antigen presentation by human endometrial cells. Journal of Steroid Biochemistry and Molecular Biology 76(1-5): 203-211
Villadangos, J.A.; Cardoso, M.; Steptoe, R.J.; van Berkel, D.; Pooley, J.; Carbone, F.R.; Shortman, K. 2001: MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14(6): 739-749
Dumortier, H.; Abbal, M.; Fort, M.; Briand, J.P.; Cantagrel, A.; Muller, S. 1999: MHC class II gene associations with autoantibodies to U1A and SmD1 proteins. International Immunology 11(2): 249-257
Azocar, J.; Clavijo, O.P.; Yunis, E.J. 2003: MHC class II genes in HCV viral clearance of hepatitis C infected Hispanic patients. Human Immunology 64(1): 99-102
Blankson, J.N.; Siliciano, R.F. 2001: MHC class Ii genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy. Journal of Clinical Investigation 107(5): 549-551
Lévéille, C.; Castaigne, J.-G.; Charron, D.; Al-Daccak, R. 2002: MHC class Ii isotype-specific signaling complex on human B cells. European Journal of Immunology 32(8): 2282-2291
Bedford, P.; Garner, K.; Knight, S.C. 1999: MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions. International Immunology 11(11): 1739-1744
Yang, T.; Zeng, H.; Zhang, J.; Okamoto, C.T.; Warren, D.W.; Wood, R.L.; Bachmann, M.; Mircheff, A.K. 1999: MHC class Ii molecules, cathepsins, and La/SSB proteins in lacrimal acinar cell endomembranes. American Journal of Physiology 277(5): C994
Kurkowska-Jastrzebska, I.; Wrońska, A.; Kohutnicka, M.; Członkowski, A.; Członkowska, A. 1999: MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease. Acta Neurobiologiae Experimentalis 59(1): 1-8
Hess, C.M.; Gasper, J.; Hoekstra, H.E.; Hill, C.E.; Edwards, S.V. 2000: MHC class II pseudogene and genomic signature of a 32-kb cosmid in the house finch (Carpodacus mexicanus). Genome Research 10(5): 613-623
Allahabadia, A.; Heward, J.M.; Nithiyananthan, R.; Gibson, S.M.; Reuser, T.T.; Dodson, P.M.; Franklyn, J.A.; Gough, S.C. 2001: MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 358(9286): 984-985
Andreae, S.; Buisson, S.; Triebel, Fédéric. 2003: MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 102(6): 2130-2137
Novak, E.J.; Liu, A.W.; Nepom, G.T.; Kwok, W.W. 1999: MHC class Ii tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza a antigen. Journal of Clinical Investigation 104(12): R63-R67
Ye, Q.; Finn, P.W.; Sweeney, R.; Bikoff, E.K.; Riese, R.J. 2003: MHC class II-associated invariant chain isoforms regulate pulmonary immune responses. Journal of Immunology 170(3): 1473-1480
Naves, R.; Lennon, A.Maria.; Barbieri, G.; Reyes, L.; Puga, G.; Salas, L.; Deffrennes, V.; Rosemblatt, M.; Fellous, M.; Charron, D.; Alcaïde-Loridan, C.; Bono, M.Rosa. 2002: MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator. International Immunology 14(5): 481-491
Poncet, P.; Arock, M.; David, B. 1999: MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation. Journal of Leukocyte Biology 66(1): 105-112
Leverkus, M.; McLellan, A.D.; Heldmann, M.; Eggert, A.O.; Bröcker, E-B.; Koch, N.; Kämpgen, E. 2003: MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways. International Immunology 15(8): 993-1006
Bertho, N.; Blancheteau, V.M.; Setterblad, N.; Laupeze, B.; Lord, J.M.; Drénou, B.; Amiot, L.; Charron, D.J.; Fauchet, Rée.; Mooney, N. 2002: MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-delta isoenzyme. International Immunology 14(8): 935-942
Hiltbold, E.M.; Poloso, N.J.; Roche, P.A. 2003: MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. Journal of Immunology 170(3): 1329-1338
Grigoriadou, K.; Ménard, C.; Pérarnau, B.; Lemonnier, F.A. 1999: MHC class Ia molecules alone control NK-mediated bone marrow graft rejection. European Journal of Immunology 29(11): 3683-3690
Rolph, M.S.; Raupach, B.; Köbernick, H.H.; Collins, H.L.; Pérarnau, B.; Lemonnier, F.A.; Kaufmann, S.H. 2001: MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis. European Journal of Immunology 31(6): 1944-1949
Mannie, M.D.; Norris, M.S. 2001: MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders. Cellular Immunology 212(1): 51-62
Donner, H.; Tönjes, R.R.; Bontrop, R.E.; Kurth, R.; Usadel, K.H.; Badenhoop, K. 2000: MHC diversity in Caucasians, investigated using highly heterogeneous noncoding sequence motifs at the DQB1 locus including a retroviral long terminal repeat element, and its comparison to nonhuman primate homologues. Immunogenetics 51(11): 898-904
Sommer, S.; Schwab, D.; Ganzhorn, J.U. 2002: MHC diversity of endemic Malagasy rodents in relation to geographic range and social system. Behavioral Ecology and Sociobiology 51(3): 214-221
Ghosh, F.; Larsson, J.; Wilke, K. 2000: MHC expression in fragment and full-thickness allogeneic embryonic retinal transplants. Graefe's Archive for Clinical and Experimental Ophthalmology 238(7): 589-598
Larsson, J.; Juliusson, B.; Holmdahl, R.; Ehinger, B. 1999: MHC expression in syngeneic and allogeneic retinal cell transplants in the rat. Graefe's Archive for Clinical and Experimental Ophthalmology 237(1): 82-85
Storch, M.K.; Weissert, R.; Steffer, A.; Birnbacher, R.; Wallström, E.; Dahlman, I.; Ostensson, C.Göran.; Linington, C.; Olsson, T.; Lassmann, H. 2002: MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury. Brain Pathology 12(3): 287-299
Wedekind, C.; Penn, D. 2000: MHC genes, body odours, and odour preferences. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 15(9): 1269-1271
Price, P.; Keane, N.M.; Stone, S.F.; Cheong, K.Y.; French, M.A. 2001: MHC haplotypes affect the expression of opportunistic infections in HIV patients. Human Immunology 62(2): 157-164
Penn, D.J.; Damjanovich, K.; Potts, W.K. 2002: MHC heterozygosity confers a selective advantage against multiple-strain infections. Proceedings of the National Academy of Sciences of the United States of America 99(17): 11260-11264
Bortolotto, S.K.; Cellini, M.; Stephenson, D.G.; Stephenson, G.M. 2000: MHC isoform composition and Ca(2+)- or Sr(2+)-activation properties of rat skeletal muscle fibers. American Journal of Physiology. Cell Physiology 279(5): C1564-C1577
Nicholls, S.M.; Williams, N.A. 2001: MHC matching and mechanisms of alloactivation in corneal transplantation. Transplantation 72(9): 1491-1497
Lake, R.A.; Robinson, B.W.; Hayball, J.D. 1999: MHC multimerization, antigen expression and the induction of APC amnesia in the developing immune response. Immunology and Cell Biology 77(1): 99-104
Gagnon, S.J.; Wang, Z.; Turner, R.; Damirjian, M.; Biddison, W.E. 2003: MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL. Journal of Immunology 171(5): 2233-2241
Kato, H.; Hayashi, M.; Fukumori, Y.; Kaneko, H. 2002: MHC restriction in contact hypersensitivity to dicyclohexylcarbodiimide. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 40(11): 1713-1718
Das, G.; Janeway, C.A. 2003: MHC specificity of iIELs. Trends in Immunology 24(2): 88-93
Bernatchez, L.; Landry, C. 2003: MHC studies in nonmodel vertebrates: what have we learned about natural selection in 15 years?. Journal of Evolutionary Biology 16(3): 363-377
De la Concha, E.G.; Fernandez-Arquero, M.; Gual, L.; Vigil, P.; Martinez, A.; Urcelay, E.; Ferreira, A.; Garcia-Rodriguez, M.C.; Fontan, G. 2002: MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. Journal of Immunology 169(8): 4637-4643
Pepys, M.B.; Bybee, A.; Booth, D.R.; Bishop, M.T.; Will, R.G.; Little, A.-M.; Prokupek, B.; Madrigal, J.A. 2003: MHC typing in variant Creutzfeldt-Jakob disease. Lancet 361(9356): 487-489
Yoshida, A.; Miyaura, M.; Sakurai, A.; Fukumori, T.; Fujita, M.; Akari, H.; Adachi, A. 2000: MHC-I expression in HTLV-1-positive and -negative cells. International Journal of Molecular Medicine 6(1): 83-86
Pedersen, A.E.; Bregenholt, S.; Johansen, B.; Skov, S.; Claesson, M.H. 1999: MHC-I-induced apoptosis in human B-lymphoma cells is dependent on protein tyrosine and serine/threonine kinases. Experimental Cell Research 251(1): 128-134
Andratschke, M.; Pauli, C.; Stein, M.; Chaubal, S.; Wollenberg, B. 2003: MHC-class i antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer. Anticancer Research 23(2b): 1467-1471
Jewett, A.; Bonavida, B. 2000: MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha. Clinical Immunology 96(1): 19-28
Stanford, L.; Brown, R.E. 2003: MHC-congenic mice (C57BL/6J and B6-H-2K) show differences in speed but not accuracy in learning the Hebb-Williams Maze. Behavioural Brain Research 144(1-2): 187-197
Hanke, T.; Takizawa, H.; Raulet, D.H. 2001: MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: Evidence for a regulated sequential model. European Journal of Immunology 31(11): 3370-3379
Bumgardner, G.L.; Gao, D.; Li, J.; Bickerstaff, A.; Orosz, C.G. 2002: MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host. Transplantation 74(6): 855-864
Ehlers, A.; Beck, S.; Forbes, S.A.; Trowsdale, J.; Volz, A.; Younger, R.; Ziegler, A. 2000: MHC-linked olfactory receptor loci exhibit polymorphism and contribute to extended HLA/OR-haplotypes. Genome Research 10(12): 1968-1978
Reichstetter, S.; Kwok, W.W.; Kochik, S.; Koelle, D.M.; Beaty, J.S.; Nepom, G.T. 1999: MHC-peptide ligand interactions establish a functional threshold for antigen-specific T cell recognition. Human Immunology 60(7): 608-618
Rau, L.; Cohen, N.; Robert, J. 2001: MHC-restricted and -unrestricted CD8 T cells: an evolutionary perspective. Transplantation 72(11): 1830-1835
Cunha-Neto, E. 1999: MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans. Brazilian Journal of Medical and Biological Research 32(2): 199-205
Karaseva, V.I. 1999: MHC-restricted interactions at different stages of in vitro formation of cells producing macrophage migration inhibitory factor. Immunologiya 4: 42-43
Pu, R.; Omori, M.; Okada, S.; Rine, S.L.; Lewis, B.A.; Lipton, E.; Yamamoto, J.K. 1999: MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors. Cellular Immunology 198(1): 30-43
Xu, X-Ning.; Screaton, G.R. 2002: MHC/peptide tetramer-based studies of T cell function. Journal of Immunological Methods 268(1): 21-28
Eckels, D.D. 2000: MHC: function and implication on vaccine development. Vox Sanguinis 78(Suppl): 265-267
Bhasin, M.; Singh, H.; Raghava, G.P.S. 2003: MHCBN: a comprehensive database of MHC binding and non-binding peptides. Bioinformatics 19(5): 665-666
Chapes, S.K.; Mosier, D.A.; Wright, A.D.; Hart, M.L. 2001: MHCII, Tlr4 and Nramp1 genes control host pulmonary resistance against the opportunistic bacterium Pasteurella pneumotropica. Journal of Leukocyte Biology 69(3): 381-386
Guan, P.; Doytchinova, I.A.; Zygouri, C.; Flower, D.R. 2003: MHCPred: a server for quantitative prediction of peptide-MHC binding. Nucleic Acids Research 31(13): 3621-3624
Kazmierczak, B.; Dal Cin, P.; Wanschura, S.; Borrmann, L.; Fusco, A.; Van Den Berghe, H.; Bullerdiek, J. 1998: HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes and Cancer 23(4): 279-285
Marten, N.W.; Stohlman, S.A.; Bergmann, C.C. 2001: MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunology 14(1): 1-18
Galperin, M.Y.; Gaidenko, T.A.; Mulkidjanian, A.Y.; Nakano, M.; Price, C.W. 2001: MHYT, a new integral membrane sensor domain. FEMS Microbiology Letters 205(1): 17-23
Müller-Ladner, U.; Bosserhoff, A.K.; Dreher, K.; Hein, R.; Neidhart, M.; Gay, S.; Schölmerich, J.; Buettner, R.; Lang, B. 1999: MIA (melanoma inhibitory activity): a potential serum marker for rheumatoid arthritis. Rheumatology 38(2): 148-154
Bosserhoff, A.K.; Lederer, M.; Kaufmann, M.; Hein, R.; Stolz, W.; Apfel, R.; Bogdahn, U.; Buettner, R. 1999: MIA, a novel serum marker for progression of malignant melanoma. Anticancer Research 19(4a): 2691-2693
Thébault, P.; Monestié, P.; McGrath, A.; Higgins, D.G. 1999: MIAH: automatic alignment of eukaryotic SSU rRNAs. Bioinformatics 15(4): 341-342
Shrewsbury, S.; Pyke, S. 2002: MIASMA: asthma exacerbation reduction with salmeterol. Chest 121(3): 1002-1004
Del Carpio-Muñoz, C.A.; Ichiishi, E.; Yoshimori, A.; Yoshikawa, T. 2002: MIAX: a new paradigm for modeling biomacromolecular interactions and complex formation in condensed phases. Proteins 48(4): 696-732
Mittal, K.; Demopoulos, R.I. 2001: MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Human Pathology 32(9): 984-987
Matsumoto, T.; Fujii, T.; Yabe, M.; Oka, K.; Hoshi, T.; Sato, K. 1998: MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults. Histopathology 33(5): 446-452
Oosterhuis, J.W.; Schapers, R.F.; Janssen-Heijnen, M.L.; Smeets, A.W.; Pauwels, R.P. 2000: MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: Clinical significance and comparison with other prognostic factors. Cancer 88(11): 2598-2605
Iqbal, S.; Anderson, T.J.; Marson, L.P.; Prescott, R.J.; Dixon, J.M.; Miller, W.R. 2002: MIB-1 assessments in breast cancers. Breast 11(3): 252-256
Zeng, Z.; Del, P.G.; Cohen, J.M.; Mittal, K. 2002: MIB-1 expression in cervical Papanicolaou tests correlates with dysplasia in subsequent cervical biopsies. Applied Immunohistochemistry and Molecular Morphology: Aimm 10(1): 15-19
Mittal, K.; Mesia, A.; Demopoulos, R.I. 1999: MIB-1 expression is useful in distinguishing dysplasia from atrophy in elderly women. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 18(2): 122-124
Rickert, D.; Mittermayer, C.; Lindenfelser, R.; Biesterfeld, S. 2000: MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland. Analytical and Quantitative Cytology and Histology 22(3): 229-234
Vlaykova, T.; Talve, L.; Hahka-Kemppinen, M.; Hernberg, M.; Muhonen, T.; Franssila, K.; Collan, Y.; Pyrhönen, S. 1999: MIB-1 immunoreactivity correlates with blood vessel density and survival in disseminated malignant melanoma. Oncology 57(3): 242-252
Pirog, E.C.; Chen, Y.T.; Isacson, C. 2000: MIB-1 immunostaining is a beneficial adjunct test for accurate diagnosis of vulvar condyloma acuminatum. American Journal of Surgical Pathology 24(10): 1393-1399
Geisler, J.P.; Geisler, H.E.; Miller, G.A.; Wiemann, M.C.; Zhou, Z.; Crabtree, W. 1999: MIB-1 in endometrial carcinoma: prognostic significance with 5-year follow-up. Gynecologic Oncology 75(3): 432-436
Levack, P.A.; Forrest, A.P.M.; Miller, E.P.; Cameron, D.A.; Anderson, E.D.; Leonard, R.C.F.; Chetty, U.; Mcintyre, M.; Miller, W.R. 1999: MIB-1 in relation to tumour response and survival in patients with breast cancer treated with primary systemic therapy. Breast 8(2): 77-83
Ho, D.M.; Hsu, C.Y.; Chiang, H. 2000: MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix. Gynecologic Oncology 76(1): 97-102
Abramovich, C.M.; Prayson, R.A. 1998: MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Human Pathology 29(12): 1420-1427
Comin, C.E.; Anichini, C.; Boddi, V.; Novelli, L.; Dini, S. 2000: MIB-1 proliferation index correlates with survival in pleural malignant mesothelioma. Histopathology 36(1): 26-31
Sandberg, D.I.; Edgar, M.A.; Resch, L.; Rutka, J.T.; Becker, L.E.; Souweidane, M.M. 2001: MIB-1 staining index of pediatric meningiomas. Neurosurgery 48(3): 590-5; Discussion 595-7
Graflund, M.; Sorbe, B.; Karlsson, M. 2002: MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome. International Journal of Oncology 20(5): 1041-1047
Popiolek, D.; Yee, H.; Levine, P.; Vamvakas, E.; Demopoulos, R.I. 2003: MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus. Gynecologic Oncology 90(2): 353-357
González-Vela, M.C.; Garijo, M.F.; Fernández, F.; Val-Bernal, J.F. 2001: MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors. Histology and Histopathology 16(2): 399-406
Biaglow, J.E.; Manevich, Y.; Leeper, D.; Chance, B.; Dewhirst, M.W.; Jenkins, W.T.; Tuttle, S.W.; Wroblewski, K.; Glickson, J.D.; Stevens, C.; Evans, S.M. 1998: MIBG inhibits respiration: Potential for radio- and hyperthermic sensitization. International Journal of Radiation Oncology Biology Physics 42(4): 871-876
Kozak, J.A.; Cahalan, M.D. 2003: MIC channels are inhibited by internal divalent cations but not ATP. Biophysical Journal 84(2 Part 1): 922-927
Hankey, K.G.; Drachenberg, C.B.; Papadimitriou, J.C.; Klassen, D.K.; Philosophe, B.; Bartlett, S.T.; Groh, V.; Spies, T.; Mann, D.L. 2002: MIC expression in renal and pancreatic allografts. Transplantation 73(2): 304-306
Fairlie, W.D.; Moore, A.G.; Bauskin, A.R.; Russell, P.K.; Zhang, H.P.; Breit, S.N. 1999: MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. Journal of Leukocyte Biology 65(1): 2-5
Wallace, G.R.; Verity, D.H.; Delamaine, L.J.; Ohno, S.; Inoko, H.; Ota, M.; Mizuki, N.; Yabuki, K.; Kondiatis, E.; Stephens, H.A.; Madanat, W.; Kanawati, C.A.; Stanford, M.R.; Vaughan, R.W. 1999: MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics 49(7-8): 613-617
Komatsu-Wakui, M.; Tokunaga, K.; Ishikawa, Y.; Kashiwase, K.; Moriyama, S.; Tsuchiya, N.; Ando, H.; Shiina, T.; Geraghty, D.E.; Inoko, H.; Juji, T. 1999: MIC-A polymorphism in Japanese and a MIC-A-MIC-B null haplotype. Immunogenetics 49(7-8): 620-628
Firsov, A.A.; Vostrov, S.N.; Shevchenko, A.A.; Zinner, S.H.; Cornaglia, G.; Portnoy, Y.A. 1998: MIC-based interspecies prediction of the antimicrobial effects of ciprofloxacin on bacteria of different susceptibilities in an in vitro dynamic model. Antimicrobial Agents and ChemoTherapy 42(11): 2848-2852
Chen, Y.; Braathen, P.; Léonard, C.; Mahillon, J. 1999: MIC231, a naturally occurring mobile insertion cassette from Bacillus cereus. Molecular Microbiology 32(3): 657-668
Stephens, H.A. 2001: MICA and MICB genes: Can the enigma of their polymorphism be resolved?. Trends in Immunology 22(7): 378-385
Das, H.; Groh, V.; Kuijl, C.; Sugita, M.; Morita, C.T.; Spies, T.; Bukowski, J.F. 2001: MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 15(1): 83-93
Ghaderi, M.; Hjelmström, P.; Hallmans, G.; Wiklund, F.; Lenner, P.; Dillner, J.; Sanjeevi, C.B. 1999: MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia. Human Immunology 60(10): 970-973
Kimura, A.; Kobayashi, Y.; Takahashi, M.; Ohbuchi, N.; Kitamura, H.; Nakamura, T.; Satoh, M.; Sasaoka, T.; Hiroi, S.; Arimura, T.; Akai, J.; Aerbajinai, W.; Yasukochi, Y.; Numano, F. 1998: MICA gene polymorphism in Takayasu's arteritis and Buerger's disease. International Journal of Cardiology 66(Suppl 1): S107-S113
Kennedy, C.; Naipal, A.; Gruis, N.A.; Struijk, L.; ter Schegget, J.; Willemze, R.; Claas, F.H.J.; Bouwes Bavinck, J.N.; Doxiadis, I.I.N. 2002: MICA gene polymorphism is not associated with an increased risk for skin cancer. Journal of Investigative Dermatology 118(4): 686-691
Picco, P.; Porfirio, B.; Gattorno, M.; Buoncompagni, A.; Falcini, F.; Cusano, R.; Bordo, D.; Pistoia, V.; Ravazzolo, R.; Seri, M. 2002: MICA gene polymorphisms in an Italian paediatric series of juvenile Behçet disease. International Journal of Molecular Medicine 10(5): 575-578
Ricci-Vitiani, L.; Vacca, A.; Potolicchio, I.; Scarpa, R.; Bitti, P.; Sebastiani, G.; Passiu, G.; Mathieu, A.; Sorrentino, R. 2000: MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia. Journal of Rheumatology 27(9): 2193-2197
Tian, W.; Boggs, D.A.; Ding, W.Z.; Chen, D.F.; Fraser, P.A. 2001: MICA genetic polymorphism and linkage disequilibrium with HLA-B in 29 African-American families. Immunogenetics 53(9): 724-728
Fodil, N.; Pellet, P.; Laloux, L.; Hauptmann, G.; Theodorou, I.; Bahram, S. 1999: MICA haplotypic diversity. Immunogenetics 49(6): 557-560
Zou, Y.; Mirbaha, F.; Lazaro, A.; Zhang, Y.; Lavingia, B.; Stastny, P. 2002: MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Human Immunology 63(1): 30-39
González, S.; Martínez-Borra, Jús.; López-Vázquez, A.; García-Fernández, S.; Torre-Alonso, J.Carlos.; López-Larrea, C. 2002: MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. Journal of Rheumatology 29(5): 973-978
Robinson, J.; Pérez-Rodríguez, M.; Waller, M.J.; Cuillerier, B.; Bahram, S.; Yao, Z.; Albert, E.D.; Madrigal, J.A.; Marsh, S.G. 2001: MICA sequences 2000. Immunogenetics 53(2): 150-169
Menier, C.; Riteau, B.éa.; Carosella, E.D.; Rouas-Freiss, N. 2002: MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal. International Journal of Cancer 100(1): 63-70
Lopez-Vazquez, A.; Rodrigo, L.; Fuentes, D.; Riestra, S.; Bousoño, C.; Garcia-Fernandez, S.; Martinez-Borra, J.ús.; Gonzalez, S.; Lopez-Larrea, C. 2002: MICA-A5.1 allele is associated with atypical forms of celiac disease in HLA-DQ2-negative patients. Immunogenetics 53(10-11): 989-991
Hassan, A.B.; Nikitina-Zake, L.; Padyukov, L.; Karlsson, Göran.; Gupta, M.; Lundberg, I.E.; Sanjeevi, C.B. 2003: MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients. Human Immunology 64(2): 290-296
Suzuki, T.; Nakamoto, T.; Ogawa, S.; Seo, S.; Matsumura, T.; Tachibana, K.; Morimoto, C.; Hirai, H. 2002: MICAL, a novel CasL interacting molecule, associates with vimentin. Journal of Biological Chemistry 277(17): 14933-14941
Weide, T.; Teuber, J.; Bayer, M.; Barnekow, A. 2003: MICAL-1 isoforms, novel rab1 interacting proteins. Biochemical and Biophysical Research Communications 306(1): 79-86
Terman, J.R.; Mao, T.; Pasterkamp, R.Jeroen.; Yu, H-Hsiang.; Kolodkin, A.L. 2002: MICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsion. Cell 109(7): 887-900
González, S.; Rodríguez-Rodero, S.; Martínez-Borra, J.ús.; López-Vázquez, A.; Rodrigo, L.; López-Larrea, C. 2003: MICB typing by PCR amplification with sequence specific primers. Immunogenetics 54(12): 850-855
Dieringer, D.; Schloetterer, C. 2003: MICROSATELLITE ANALYSER (MSA): A platform independent analysis tool for large microsatellite data sets. Molecular Ecology Notes 3(1): 167-169
Sreenu, V.B.; Alevoor, V.; Nagaraju, J.; Nagarajaram, H.A. 2003: MICdb: database of prokaryotic microsatellites. Nucleic Acids Research 31(1): 106-108
Mishra, S.K.; Mazumdar, A.; Vadlamudi, R.K.; Li, F.; Wang, R-An.; Yu, W.; Jordan, V.Craig.; Santen, R.J.; Kumar, R. 2003: MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. Journal of Biological Chemistry 278(21): 19209-19219
Short, K.M.; Hopwood, B.; Yi, Z.; Cox, T.C. 2002: MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. Bmc Cell Biology 3: 1
Buchner, G.; Montini, E.; Andolfi, G.; Quaderi, N.; Cainarca, S.; Messali, S.; Bassi, M.T.; Ballabio, A.; Meroni, G.; Franco, B. 1999: MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development. Human Molecular Genetics 8(8): 1397-1407
Inoue, T.; Shoji, W.; Obinata, M. 2000: MIDA1 is a sequence specific DNA binding protein with novel DNA binding properties. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 5(9): 699-709
Inoue, T.; Shoji, W.; Obinata, M. 1999: MIDA1, an Id-associating protein, has two distinct DNA binding activities that are converted by the association with Id1: a novel function of Id protein. Biochemical and Biophysical Research Communications 266(1): 147-151
Leng, L.; Metz, C.N.; Fang, Y.; Xu, J.; Donnelly, S.; Baugh, J.; Delohery, T.; Chen, Y.; Mitchell, R.A.; Bucala, R. 2003: MIF signal transduction initiated by binding to CD74. Journal of Experimental Medicine 197(11): 1467-1476
Ruehlmann, J.M.; Xiang, R.; Niethammer, A.G.; Ba, Y.; Pertl, U.; Dolman, C.S.; Gillies, S.D.; Reisfeld, R.A. 2001: MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. Cancer Research 61(23): 8498-8503
Spandau, U.; Toksoy, A.; Goebeler, M.; Bröcker, E.B.; Gillitzer, R. 1998: MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions. Journal of Investigative Dermatology 111(6): 1003-1009
Alberti, A.; Lodi, T.; Ferrero, I.; Donnini, C. 2003: MIG1-dependent and MIG1-independent regulation of GAL gene expression in Saccharomyces cerevisiae: role of Imp2p. Yeast 20(13): 1085-1096
Mcconchie, J., A.; Ma-Huan-Cheng 2003: MIGIS: An effective tool to negotiate development interventions relating to forestry. Journal of Forestry Research 14(1): 9-18
Woodings, J.A.; Sharp, S.J.; Machesky, L.M. 2003: MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochemical Journal 371(Part 2): 463-471
Ignatova, M.; Lubenova, V.; Georgieva, P. 2000: MIMO adaptive linearizing control of fed-batch amino acids simultaneous production. Bioprocess Engineering 22(1): 79-84
Jewett, A.I.; Huang, C.C.; Ferrin, T.E. 2003: MINRMS: an efficient algorithm for determining protein structure similarity using root-mean-squared-distance. Bioinformatics 19(5): 625-634
Zanzoni, A.; Montecchi-Palazzi, L.; Quondam, M.; Ausiello, G.; Helmer-Citterich, M.; Cesareni, G. 2002: MINT: A molecular INTeraction database. FEBS Letters 513(1): 135-140
Wada, T.; Furuichi, K.; Segawa-Takaeda, C.; Shimizu, M.; Sakai, N.; Takeda, S.I.; Takasawa, K.; Kida, H.; Kobayashi, K.I.; Mukaida, N.; Ohmoto, Y.; Matsushima, K.; Yokoyama, H. 1999: MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney International 56(3): 995-1003
Rumsey, L.M.; Teague, R.M.; Benedict, S.H.; Chan, M.A. 2001: MIP-1alpha induces activation of phosphatidylinositol-3 kinase that associates with Pyk-2 and is necessary for B-cell migration. Experimental Cell Research 268(1): 77-83
Kernacki, K.A.; Barrett, R.P.; McClellan, S.; Hazlett, L.D. 2001: MIP-1alpha regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection. Journal of Leukocyte Biology 70(6): 911-919
Ousman, S.S.; David, S. 2001: MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 21(13): 4649-4656
Dorner, B.G.; Scheffold, A.; Rolph, M.S.; Huser, M.B.; Kaufmann, S.H.E.; Radbruch, A.; Flesch, I.E.A.; Kroczek, R.A. 2002: MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proceedings of the National Academy of Sciences of the United States of America 99(9): 6181-6186
Ohtsuka, Y.; Lee, J.; Stamm, D.S.; Sanderson, I.R. 2001: MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut 49(4): 526-533
Sullivan, S.K.; McGrath, D.A.; Liao, F.; Boehme, S.A.; Farber, J.M.; Bacon, K.B. 1999: MIP-3alpha induces human eosinophil migration and activation of the mitogen-activated protein kinases (p42/p44 MAPK). Journal of Leukocyte Biology 66(4): 674-682
Niu, Y.; Murata, T.; Watanabe, K.; Kawakami, K.; Yoshimura, A.; Inoue, J-ichiro.; Puri, R.K.; Kobayashi, N. 2003: MIP-T3 associates with IL-13Ralpha1 and suppresses STAT6 activation in response to IL-13 stimulation. Febs Letters 550(1-3): 139-143
Ling, L.; Goeddel, D.V. 2000: MIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule network. Journal of Biological Chemistry 275(31): 23852-23860
Chianella, I.; Piletsky, S.A.; Tothill, I.E.; Chen, B.; Turner, A.P.F. 2003: MIP-based solid phase extraction cartridges combined with MIP-based sensors for the detection of microcystin-LR. Biosensors and Bioelectronics 18(2-3): 119-127
Miquel de Càceres; Villà, J.; Lozano, J.J.; Sanz, F. 2000: MIPSIM: similarity analysis of molecular interaction potentials. Bioinformatics 16(6): 568-569
Olsson, P.A.; Korhonen, L.; Mercer, E.A.; Lindholm, D. 1999: MIR is a novel ERM-like protein that interacts with myosin regulatory light chain and inhibits neurite outgrowth. Journal of Biological Chemistry 274(51): 36288-36292
Ozawa, T.; Minakawa, T.; Saito, A.; Yoneoka, Y.; Yoshimura, J.; Arai, H. 2001: MRA demonstration of "periarteritis" in Tolosa-Hunt syndrome. Acta Neurochirurgica 143(3): 309-312
Bouchet, L.G.; Bolch, W.E.; Blanco, H.Pablo.; Wessels, B.W.; Siegel, J.A.; Rajon, D.A.; Clairand, I.; Sgouros, G. 2003: MIRD Pamphlet No 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(7): 1113-1147
Thomas, S.R. 2001: MIRD Pamphlet no. 18: Administered cumulated activity for ventilation studies. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 42(3): 520-526
Goitsuka, R.; Tatsuno, A.; Ishiai, M.; Kurosaki, T.; Kitamura, D. 2001: MIST functions through distinct domains in immunoreceptor signaling in the presence and absence of LAT. Journal of Biological Chemistry 276(38): 36043-36050
Schweitz, H.; Pacaud, P.; Diochot, S.; Moinier, D.; Lazdunski, M. 1999: MIT(1), a black mamba toxin with a new and highly potent activity on intestinal contraction. FEBS Letters 461(3): 183-188
Tachibana, M. 2000: MITF: A stream flowing for pigment cells. Pigment Cell Research 13(4): 230-240
Stadt, K.J.; Lieffers, V.J. 2000: MIXLIGHT: A flexible light transmission model for mixed-species forest stands. Agricultural and Forest Meteorology 102(4): 235-252
Bächner, D.; Kreienkamp, H-Jürgen.; Richter, D. 2002: MIZIP, a highly conserved, vertebrate specific melanin-concentrating hormone receptor 1 interacting zinc-finger protein. FEBS Letters 526(1-3): 124-128
Li, W.T.; Sandman, K.; Pereira, S.L.; Reeve, J.N. 2000: MJ1647, an open reading frame in the genome of the hyperthermophile Methanococcus jannaschii, encodes a very thermostable archaeal histone with a C-terminal extension. Extremophiles: Life Under Extreme Conditions 4(1): 43-51
Gerlach, R.üd.; Beck, M.; Zeitschel, U.; Seifert, V. 2002: MK 801 attenuates c-Fos and c-Jun expression after in vitro ischemia in rat neuronal cell cultures but not in PC 12 cells. Neurological Research 24(7): 725-729
Barlage, S.; Wimmer, A.; Pfeiffer, A.; Rothe, G.; Schmitz, G. 2002: MK-383 (tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor. Platelets 13(3): 133-140
Guasch, A.; Zayas, C.F.; Badr, K.F. 1999: MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis. Kidney International 56(1): 261-267
Kennaway, D.J.; Moyer, R.W. 1999: MK-801 administration blocks the effects of a 5-HT(2A/2C) agonist on melatonin rhythmicity and c-fos induction in the suprachiasmatic nucleus. Brain Research 845(1): 102-106
Van De Witte, S.V.; Groenewegen, H.J.; Voorn, P. 2002: MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. Synapse 43(1): 1-11
Zeng, J.B.; Li, W.B.; Li, Q.J.; Chen, X.L.; Zhou, A.M.; Ling, Y.L. 2001: MK-801 attenuates NOS expression and NO content in the spinal cord of rats with inflammatory pain. Sheng Li Xue Bao: 53(1): 55-60
Gaytan, O.; Nason, R.; Alagugurusamy, R.; Swann, A.; Dafny, N. 2000: MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate. Brain Research Bulletin 51(6): 485-492
Thomas, J.D.; Fleming And, S.L.; Riley, E.P. 2001: MK-801 can exacerbate or attenuate behavioral alterations associated with neonatal alcohol exposure in the rat, depending on the timing of administration. Alcoholism Clinical and Experimental Research 25(5): 764-773
Gould, T.J.; McCarthy, M.M.; Keith, R.A. 2002: MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning. Behavioural Pharmacology 13(4): 287-294
Hlinák, Z.; Krejcí, I. 2002: MK-801 induced amnesia for the elevated plus-maze in mice. Behavioural Brain Research 131(1-2): 221-225
Harrod, S.B.; Flint, R.W.; Riccio, D.C. 2001: MK-801 induced retrieval, but not acquisition, deficits for passive avoidance conditioning. Pharmacology Biochemistry and Behavior 69(3-4): 585-593
Ishida, F.; Sato, T.; Imaizumi, M.; Funayama, N.; Ikegami, K.; Nimura, T.; Kawatani, M. 2003: MK-801 inhibits the micturition reflex in chronic bladder irritation caused by crystalluria in the rat. Autonomic Neuroscience: Basic and Clinical 105(1): 1-7
Iravani, M.M.; Muscat, R.; Kruk, Z.L. 1999: MK-801 interaction with the 5-HT transporter: a real-time study in brain slices using fast cyclic voltammetry. Synapse 32(3): 212-224
Toth, J.F.; Parker, L.A. 1999: MK-801 interferes with the acquisition of amphetamine- and lithium-induced place conditioning. Animal Learning and Behavior 27(4): 481-489
Hirayama, M.; Kuriyama, M. 2001: MK-801 is cytotoxic to microglia in vitro and its cytotoxicity is attenuated by glutamate, other excitotoxic agents and atropine. Possible presence of glutamate receptor and muscarinic receptor on microglia. Brain Research 897(1-2): 204-206
Fix, A.S.; Stitzel, S.R.; Ridder, G.M.; Switzer, R.C. 2000: MK-801 neurotoxicity in cupric silver-stained sections: lesion reconstruction by 3-dimensional computer image analysis. Toxicologic Pathology 28(1): 84-90
Campbell, B.M.; Walker, P.D. 2001: MK-801 prevents dopamine D1 but not serotonin 2A stimulation of striatal preprotachykinin mRNA expression. Neuroreport 12(5): 953-955
Kosai, K.; Tateyama, S.; Ikeda, T.; Uno, T.; Nishimori, T.; Takasaki, M. 2001: MK-801 reduces non-noxious stimulus-evoked Fos-like immunoreactivity in the spinal cord of rats with chronic constriction nerve injury. Brain Research 910(1-2): 12-18
Wei, H.; Pertovaara, A. 1999: MK-801, an NMDA receptor antagonist, in the rostroventromedial medulla attenuates development of neuropathic symptoms in the rat. Neuroreport 10(14): 2933-2937
Hanania, T.; Mccreary, A.C.; Haughey, H.M.; Salaz, D.O.; Zahniser, N.R. 2002: MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: Dopamine and serotonin systems. European Journal of Pharmacology 457(2-3): 125-135
Castellano, C.; Cestari, V.; Ciamei, A.; Pavone, F. 1999: MK-801-induced disruptions of one-trial inhibitory avoidance are potentiated by stress and reversed by naltrexone. Neurobiology of Learning and Memory 72(3): 215-229
Madsen, M.; Lublin, H. 1998: MK-801-induced dystonia in cebus monkeys. Clinical Neuropharmacology 21(6): 333-338
Zhang, X.; Fan, X.; Mohapel, P.; Yu, P.H.; Boulton, A.A. 1999: MK-801-induced expression of Fos protein family members in the rat retrosplenial granular cortex. Journal of Neuroscience Research 57(5): 719-729
Zahniser, N.R.; Negri, C.A.; Hanania, T.; Gehle, V.M. 1999: MK-801-induced locomotor activity in long-sleep x short-sleep recombinant inbred mouse strains: correlational analysis with low-dose ethanol and provisional quantitative trait loci. Alcoholism Clinical and Experimental Research 23(11): 1721-1729
Jan, C.R.; Tseng, C.J. 2000: MK-886, a leukotriene biosynthesis inhibitor, as an activator of Ca(2+) mobilization in Madin-Darby canine kidney (MDCK) cells. Journal of Pharmacology and Experimental Therapeutics 294(1): 96-102
Barsotti, A.; Di Napoli, P.; Taccardi, A.A.; Spina, R.; Stuppia, L.; Palka, G.; Barbacane, R.C.; De Caterina, R.; Conti, P. 2001: MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: Evidence of an e-NOS mRNA overexpression after global ischemia. Atherosclerosis 155(1): 53-59
Gendron, R.L.; Liu, C.Y.; Paradis, H.; Adams, L.C.; Kao, W.W. 2001: MK/T-1, an immortalized fibroblast cell line derived using cultures of mouse corneal stroma. Molecular Vision 7: 107-113
Neininger, A.; Kontoyiannis, D.; Kotlyarov, A.; Winzen, R.; Eckert, R.; Volk, H.-D.; Holtmann, H.; Kollias, G.; Gaestel, M. 2002: MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. Journal of Biological Chemistry 277(5): 3065-3068
Yoshimoto, Y.; Sawa, T.; Kinoshita, N.; Homma, Y.; Hamada, M.; Takeuchi, T.; Imoto, M. 2000: MK800-62F1, a new inhibitor of apoptotic cell death, from Streptomyces diastatochromogenes MK800-62F1. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. Journal of Antibiotics 53(6): 569-574
Yoshimoto, Y.; Sawa, T.; Naganawa, H.; Sugai, T.; Takeuchi, T.; Imoto, M. 2000: MK800-62F1, a new inhibitor of apoptotic cell death, from Streptomyces diastatochromogenes MK800-62F1. II. Structure elucidation. Journal of Antibiotics 53(6): 575-578
Ichord, R.N.; Johnston, M.V.; Traystman, R.J. 2001: MK801 decreases glutamate release and oxidative metabolism during hypoglycemic coma in piglets. Brain Research. Developmental Brain Research 128(2): 139-148
Canini, F.éd.ér.; Simler, N.; Bourdon, L. 2002: MK801 impairs thermoregulation in the heat. Canadian Journal of Physiology and Pharmacology 80(3): 226-232
Schmidt, J.T.; Buzzard, M.; Borress, R.; Dhillon, S. 2000: MK801 increases retinotectal arbor size in developing zebrafish without affecting kinetics of branch elimination and addition. Journal of Neurobiology 42(3): 303-314
Jonkers, N.; Sarre, S.; Ebinger, G.; Michotte, Y. 2000: MK801 influences L-DOPA-induced dopamine release in intact and hemi-parkinson rats. European Journal of Pharmacology 407(3): 281-291
Jonkers, N.; Sarre, S.; Ebinger, G.; Michotte, Y. 2002: MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats. Brain Research 926(1-2): 149-155
Robinson, V.L.; Hickson, J.A.; Vander Griend, D.J.; Dubauskas, Z.; Rinker-Schaeffer, C.W. 2003: MKK4 and metastasis suppression: A marriage of signal transduction and metastasis research. Clinical and Experimental Metastasis 20(1): 25-30
Fujishiro, M.; Gotoh, Y.; Katagiri, H.; Sakoda, H.; Ogihara, T.; Anai, M.; Onishi, Y.; Ono, H.; Funaki, M.; Inukai, K.; Fukushima, Y.; Kikuchi, M.; Oka, Y.; Asano, T. 2001: MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. Journal of Biological Chemistry 276(23): 19800-19806
Rumora, L.; Shaver, A.; Zanic Grubisic, T.; Maysinger, D. 2001: MKP-1 as a target for pharmacological manipulations in PC12 cell survival. Neurochemistry International 39(1): 25-32
Masuda, K.; Shima, H.; Watanabe, M.; Kikuchi, K. 2001: MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein. Journal of Biological Chemistry 276(42): 39002-39011
Zwingmann, W.; Fiedler, J. 2001: MKS und internationale Handelsbeziehungen: Konditionen und Konsequenzen. Deutsche Tierärztliche Wochenschrift 108(12): 518-521
Alioum, A.; Commenges, D. 2001: MKVPCI: A computer program for Markov models with piecewise constant intensities and covariates. Computer Methods and Programs in Biomedicine 64(2): 109-119
Odani, K.; Kobayashi, T.; Ogawa, Y.; Yoshida, S.; Seguchi, H. 2003: ML-7 inhibits exocytosis of superoxide-producing intracellular compartments in human neutrophils stimulated with phorbol myristate acetate in a myosin light chain kinase-independent manner. Histochemistry and Cell Biology 119(5): 363-370
Tian, B.; Brumback, L.C.; Kaufman, P.L. 2000: ML-7, chelerythrine and phorbol ester increase outflow facility in the monkey Eye. Experimental Eye Research 71(6): 551-566
Ito, S.; Kume, H.; Katoh, H.; Honjo, H.; Yamaki, K.; Kodama, I. 2001: ML-9 inhibits methacholine-induced Ca2+ mobilization in guinea pig tracheal smooth muscle. Environmental Medicine 45(1): 45-47
Vucic, D.; Stennicke, H.R.; Pisabarro, M.T.; Salvesen, G.S.; Dixit, V.M. 2000: ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Current Biology: Cb 10(21): 1359-1366
Inohara, N.; Nuñez, G. 2002: ML -- a conserved domain involved in innate immunity and lipid metabolism. Trends in Biochemical Sciences 27(5): 219-221
Du, J.; Miller, A.J.; Widlund, H.R.; Horstmann, M.A.; Ramaswamy, S.; Fisher, D.E. 2003: MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. American Journal of Pathology 163(1): 333-343
Franco, D.; Kelly, R.; Moorman, A.F.; Lamers, W.H.; Buckingham, M.; Brown, N.A. 2001: MLC3F transgene expression in iv mutant mice reveals the importance of left-right signalling pathways for the acquisition of left and right atrial but not ventricular compartment identity. Developmental Dynamics: An Official Publication of the American Association of Anatomists 221(2): 206-215
Stenberg, P.; Lundmark, M.; Saura, A. 2003: MLGsim: A program for detecting clones using a simulation approach. Molecular Ecology Notes 3(2): 329-331
Berends, M.J.; Hollema, H.; Wu, Y.; van Der Sluis, T.; Mensink, R.G.; ten Hoor, K.A.; Sijmons, R.H.; de Vries, E.G.; Pras, E.; Mourits, M.J.; Hofstra, R.M.; Buys, C.H.; Kleibeuker, J.H.; van Der Zee, A.G. 2001: MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. International Journal of Cancer 92(3): 398-403
Paraf, F.; Gilquin, M.; Longy, M.; Gilbert, B.; Gorry, P.; Petit, B.; Labrousse, F. 2001: MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 39(3): 250-258
Hoffmann, E.R.; Shcherbakova, P.V.; Kunkel, T.A.; Borts, R.H. 2003: MLH1 mutations differentially affect meiotic functions in Saccharomyces cerevisiae. Genetics 163(2): 515-526
Simpkins, S.B.; Bocker, T.; Swisher, E.M.; Mutch, D.G.; Gersell, D.J.; Kovatich, A.J.; Palazzo, J.P.; Fishel, R.; Goodfellow, P.J. 1999: MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Human Molecular Genetics 8(4): 661-666
Lipkin, S.M.; Wang, V.; Jacoby, R.; Banerjee Basu, S.; Baxevanis, A.D.; Lynch, H.T.; Elliott, R.M.; Collins, F.S. 2000: MLH3: A DNA mismatch repair gene associated with mammalian microsatellite instability. Nature Genetics 24(1): 27-35
Diaz, M.; Martin, B.; Rodriguez, M. 2001: MLISO, a computer simulation of experiments to illustrate the cellular basis of intestinal muscle activity. Journal of Physiology and Biochemistry 57(2): 89-94
Michaux, L.; Wlodarska, I.; Stul, M.; Dierlamm, J.; Mugneret, F.; Herens, C.; Beverloo, B.; Verhest, A.; Verellen-Dumoulin, C.; Verhoef, G.; Selleslag, D.; Madoe, V.; Lecomte, M.; Deprijck, B.; Ferrant, A.; Delannoy, A.; Marichal, S.; Duhem, C.; Dicato, M.; Hagemeijer, A. 2000: MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23. Genes Chromosomes and Cancer 29(1): 40-47
Dolan, M.; Mcglennen, R.C.; Hirsch, B. 2002: MLL amplification in myeloid malignancies: Clinical, molecular, and cytogenetic findings. Cancer Genetics and Cytogenetics 134(2): 93-101
Ernst, P.; Wang, J.; Huang, M.; Goodman, R.H.; Korsmeyer, S.J. 2001: MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Molecular and Cellular Biology 21(7): 2249-2258
Fukushima, T.; Yoshio, N.; Noto, Y.; Kida, H. 2002: MLL gene rearrangement in acute myelogenous leukemia after exposure to tegafur/uracil. International Journal of Hematology 75(2): 178-181
Shimoda, K.; Sugio, Y.; Miyahara, M.; Watanabe, K.; Tokunaga, Y.; Asano, Y.; Gondo, H.; Okamura, T.; Niho, Y. 2000: MLL gene rearrangement in t(9;11) acute myelogenous leukemia with minimal myeloid differentiation (FAB subtype M0). International Journal of Hematology 71(3): 245-248
Fleischman, E.W.; Reshmi, S.; Frenkel, M.A.; Konovalova, W.I.; Guleva, G.P.; Kulagina, O.E.; Konstantinova, L.N.; Tupitsyn, N.N.; Rowley, J.D. 1999: MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia. Genes Chromosomes and Cancer 24(2): 151-155
Milne, T.A.; Briggs, S.D.; Brock, H.W.; Martin, M.Ellen.; Gibbs, D.; Allis, C.David.; Hess, J.L. 2002: MLL targets SET domain methyltransferase activity to Hox gene promoters. Molecular Cell 10(5): 1107-1117
So, C.Wai.; Cleary, M.L. 2002: MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Molecular and Cellular Biology 22(18): 6542-6552
Sugita, K.; Taki, T.; Hayashi, Y.; Shimaoka, H.; Kumazaki, H.; Inoue, H.; Konno, Y.; Taniwaki, M.; Kurosawa, H.; Eguchi, M. 2000: MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia. Genes Chromosomes and Cancer 27(3): 264-269
Schulte, C.E.; Von Lindern, M.; Steinlein, P.; Beug, H.; Wiedemann, L.M. 2002: MLL-ENL cooperates with SCF to transform primary avian multipotent cells. EMBO Journal 21(16): 4297-4306
So, C.Wai.; Karsunky, H.; Passegué, E.; Cozzio, A.; Weissman, I.L.; Cleary, M.L. 2003: MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell 3(2): 161-171
Kim, H-Jin.; Ki, C-Seok.; Park, Q.; Koo, H-Hoe.; Yoo, K-Hee.; Kim, E-Jeong.; Kim, S-Hee. 2003: MLL/SEPTIN6 chimeric transcript from inv ins(X;11)(q24;q23q13) in acute monocytic leukemia: report of a case and review of the literature. Genes Chromosomes and Cancer 38(1): 8-12
FitzGerald, K.T.; Diaz, M.O. 1999: MLL2: A new mammalian member of the trx/MLL family of genes. Genomics 59(2): 187-192
Ruault, M.; Brun, M.Elisabeth.; Ventura, M.; Roizès, Gérard.; De Sario, A. 2002: MLL3, a new human member of the TRX/MLL gene family, maps to 7q36, a chromosome region frequently deleted in myeloid leukaemia. Gene 284(1-2): 73-81
Zhang, M.; Liu, P.; Dwyer, N.K.; Christenson, L.K.; Fujimoto, T.; Martinez, F.; Comly, M.; Hanover, J.A.; Blanchette-Mackie, E.J.; Strauss, J.F. 2002: MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. Journal of Biological Chemistry 277(36): 33300-33310
Zhao, S.; Zhang, Y.K.Y.; Harris, S.; Ahuja, S.S.; Bonewald, L.F. 2002: MLO-Y4 osteocyte-like cells support osteoclast formation and activation. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 17(11): 2068-2079
Portillo, A.; Lantero, M.; Olarte, I.; Ruiz-Larrea, F.; Torres, C. 2001: MLS resistance phenotypes and mechanisms in beta-haemolytic group B, C and G Streptococcus isolates in la Rioja, Spain. Journal of Antimicrobial ChemoTherapy 47(1): 115-116
Wightman, P.J.; Santer, R.; Ribes, A.; Dougherty, F.; McGill, N.; Thorburn, D.R.; FitzPatrick, D.R. 2003: MLYCD mutation analysis: evidence for protein mistargeting as a cause of MLYCD deficiency. Human Mutation 22(4): 288-300
Fujioka, Y.; Taira, T.; Maeda, Y.; Tanaka, S.; Nishihara, H.; Iguchi-Ariga, S.M.; Nagashima, K.; Ariga, H. 2001: MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer. Journal of Biological Chemistry 276(48): 45137-45144
Mori, K.; Maeda, Y.; Kitaura, H.; Taira, T.; Iguchi-Ariga, S.M.; Ariga, H. 1998: MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc. Journal of Biological Chemistry 273(45): 29794-29800
Gindreau, E.; López, R.; García, P. 2000: MM1, a temperate bacteriophage of the type 23F Spanish/USA multiresistant epidemic clone of Streptococcus pneumoniae: structural analysis of the site-specific integration system. Journal of Virology 74(17): 7803-7813
Dowd, M.; Rockey, W.; French, A.; Reilly, P. 2002: MM3 modeling of aldopentose pyranose rings. Journal of carbohydrate chemistry: 1-25
Stortz, C.A.; Cerezo, A.S. 2003: MM3 potential energy surfaces of the 2-linked glucosyl trisaccharides alpha-kojitriose and beta-sophorotriose. Carbohydrate Research 338(16): 1679-1689
Lee, J.Ho.; Oh, S.Heang. 2002: MMA/MPEOMA/VSA copolymer as a novel blood-compatible material: Effect of PEO and negatively charged side chains on protein adsorption and platelet adhesion. Journal of Biomedical Materials Research 60(1): 44-52
Koul, D.; Shen, R.; Garyali, A.; Ke, L.D.; Liu, T-Jen.; Yung, W.K.Alfred. 2002: MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. International Journal of Oncology 21(3): 469-475
Zhao-Changlin; Xu-Huimian; Liu-Jia; Et-Al 2002: MMC-induced apoptosis and expression of Fas/FasL and caspase-3 genes in EJ cells. Zhongguo Zhongliu Linchuang 29(6): 400-403
Poorafshar, M.; Helmby, H.; Troye-Blomberg, M.; Hellman, L. 2000: MMCP-8, the first lineage-specific differentiation marker for mouse basophils. Elevated numbers of potent IL-4-producing and MMCP-8-positive cells in spleens of malaria-infected mice. European Journal of Immunology 30(9): 2660-2668
Perry-Rana, S.R.; Housh, T.J.; Johnson, G.O.; Bull, A.J.; Berning, J.M.; Cramer, J.T. 2002: MMG and EMG responses during fatiguing isokinetic muscle contractions at different velocities. Muscle and Nerve 26(3): 367-373
Bellovino, D.; Lanyau, Y.; Garaguso, I.; Amicone, L.; Cavallari, C.; Tripodi, M.; Gaetani, S. 1999: MMH cells: An in vitro model for the study of retinol-binding protein secretion regulated by retinol. Journal of Cellular Physiology 181(1): 24-32
Pazo-Alvarez, P.; Cadaveira, F.; Amenedo, E. 2003: MMN in the visual modality: A review. Biological Psychology 63(3): 199-236
Pasterkamp, G.; Sierevogel, M.J.; de Kleijn, D.P.V.; Strauss, B.H. 2002: MMP inhibition and lumen loss after balloon angioplasty or stenting. Arteriosclerosis Thrombosis and Vascular Biology 22(7): 1241; Author Reply 1241
Li, Y.You.; Kadokami, T.; Wang, P.; McTiernan, C.F.; Feldman, A.M. 2002: MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure. American Journal of Physiology. Heart and Circulatory Physiology 282(3): H983-H989
Ho, A.T.; Voura, E.B.; Soloway, P.D.; Watson, K.L.; Khokha, R. 2001: MMP inhibitors augment fibroblast adhesion through stabilization of focal adhesion contacts and up-regulation of cadherin function. Journal of Biological Chemistry 276(43): 40215-40224
D'angelo, M.; Yan, Z.; Nooreyazdan, M.; Pacifici, M.; Sarment, D.S.; Billings, P.C.; Leboy, P.S. 2000: MMP-13 is induced during chondrocyte hypertrophy. Journal of Cellular Biochemistry 77(4): 678-693
Djonov, V.; Högger, K.; Sedlacek, R.; Laissue, J.; Draeger, A. 2001: MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. Journal of Pathology 195(2): 147-155
Cai, D.H.; Vollberg, T.M.; Hahn-Dantona, E.; Quigley, J.P.; Brauer, P.R. 2000: MMP-2 Expression during early avian cardiac and neural crest morphogenesis. Anatomical Record 259(2): 168-179
Kuittinen, O.; Savolainen, E.R.; Koistinen, P.; Möttönen, M.; Turpeenniemi-Hujanen, T. 2001: MMP-2 and MMP-9 expression in adult and childhood acute lymphatic leukemia (ALL). Leukemia Research 25(2): 125-131
Singer, C.F.; Kronsteiner, N.; Marton, E.; Kubista, M.; Cullen, K.J.; Hirtenlehner, K.; Seifert, M.; Kubista, E. 2002: MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Research and Treatment 72(1): 69-77
Ferguson, T.A.; Muir, D. 2000: MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Molecular and Cellular Neurosciences 16(2): 157-167
Bloomston, M.; Shafii, A.; Zervos, E.E.; Rojiani, A.; Rosemurgy, A.S. 2002: MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer. Journal of Surgical Research 102(1): 35-38
Davidson, B.; Goldberg, I.; Kopolovic, J.; Lerner-Geva, L.; Gotlieb, W.H.; Ben-Baruch, G.; Reich, R. 1999: MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecologic Oncology 73(3): 372-382
Nakopoulou, L.; Tsirmpa, I.; Alexandrou, P.; Louvrou, A.; Ampela, C.; Markaki, S.; Davaris, P.S. 2003: MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival. Breast Cancer Research and Treatment 77(2): 145-155
Krengel, S.; Alexander, M.; Brinckmann, J.; Tronnier, M. 2002: MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UVB-light. Journal of Cutaneous Pathology 29(7): 390-396
Cataldo, D.; Munaut, C.; Noël, A.; Frankenne, F.; Bartsch, P.; Foidart, J.M.; Louis, R. 2000: MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. International Archives of Allergy and Immunology 123(3): 259-267
Marchenko, G.N.; Strongin, A.Y. 2001: MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. Gene 265(1-2): 87-93
Nakopoulou, L.; Gakiopoulou, H.; Zervas, A.; Giannopoulou, I.; Constantinides, C.; Lazaris, A.C.; Liapis, H.; Kyriakou, G.; Dimopoulos, C. 2001: MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: a comparison with clinicopathologic features and survival. Applied Immunohistochemistry and Molecular Morphology: Aimm 9(2): 130-137
Huo, N.; Ichikawa, Y.; Kamiyama, M.; Ishikawa, T.; Hamaguchi, Y.; Hasegawa, S.; Nagashima, Y.; Miyazaki, K.; Shimada, H. 2002: MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Letters 177(1): 95-100
Nwomeh, B.C.; Liang, H.X.; Cohen, I.K.; Yager, D.R. 1999: MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. Journal of Surgical Research 81(2): 189-195
Nyberg, P.; Moilanen, M.; Paju, A.; Sarin, A.; Stenman, U-H.; Sorsa, T.; Salo, T. 2002: MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells. Journal of Dental Research 81(12): 831-835
Bhattacharjee, A.Kumar.; Kondoh, T.; Ikeda, M.; Kohmura, E. 2002: MMP-9 and EBA immunoreactivity after papaverine mediated opening of the blood-brain barrier. Neuroreport 13(17): 2217-2221
Sharshar, T.; Durand, M-C.; Lefaucheur, J-P.; Lofaso, F.; Raphaël, J-C.; Gherardi, R.K.; Créange, A. 2002: MMP-9 correlates with electrophysiologic abnormalities in Guillain-Barré syndrome. Neurology 59(10): 1649-1651
El-Shabrawi, Y.; Ardjomand, N.; Radner, H.; Ardjomand, N. 2001: MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma. Journal of Pathology 194(2): 201-206
Coussens, L.M.; Tinkle, C.L.; Hanahan, D.; Werb, Z. 2000: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103(3): 481-490
Stratmann, B.; Farr, M.; Tschesche, H. 2001: MMP-TIMP interaction depends on residue 2 in TIMP-4. FEBS Letters 507(3): 285-287
Duchossoy, Y.; Horvat, J.C.; Stettler, O. 2001: MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites. Molecular and Cellular Neurosciences 17(6): 945-956
Li, H.; Simon, H.; Bocan, T.M.; Peterson, J.T. 2000: MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition. Cardiovascular Research 46(2): 298-306
Fortunato, S.J.; Menon, R.; Lombardi, S.J. 1999: MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. Journal of Perinatal Medicine 27(5): 362-368
Biondi, M.L.; Turri, O.; Leviti, S.; Seminati, R.; Cecchini, F.; Bernini, M.; Ghilardi, G.; Guagnellini, E. 2000: MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clinical Chemistry 46(12): 2023-2024
Yoon, S.; Kuivaniemi, H.; Gatalica, Z.; Olson, J.M.; Butticè, G.; Ye, S.; Norris, B.A.; Malcom, G.T.; Strong, J.P.; Tromp, G. 2002: MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males. Matrix Biology: Journal of the International Society for Matrix Biology 21(6): 487-498
Théret, N.; Lehti, K.; Musso, O.; Clément, B. 1999: MMP2 activation by collagen i and concanavalin a in cultured human hepatic stellate cells. Hepatology 30(2): 462-468
Hiratsuka, S.; Nakamura, K.; Iwai, S.; Murakami, M.; Itoh, T.; Kijima, H.; Shipley, J.Michael.; Senior, R.M.; Shibuya, M. 2002: MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2(4): 289-300
Lepidi, S.; Kenagy, R.D.; Raines, E.W.; Chiu, E.S.; Chait, A.; Ross, R.; Clowes, A.W. 2001: MMP9 production by human monocyte-derived macrophages is decreased on polymerized type i collagen. Journal of Vascular Surgery 34(6): 1111-1118
Subotnik, K.L.; Nuechterlein, K.H.; Ventura, J. 2000: MMPI discriminators of deficit vs. non-deficit recent-onset schizophrenia patients. Psychiatry Research 93(2): 111-123
Fan, A.Y.; Zhou, A.N. 1999: MMPi manifestations of Chinese migraine syndromes: a control study. American Journal of Chinese Medicine 27(1): 37-42
Carter, J.W.; Parnas, J.; Cannon, T.D.; Schulsinger, F.; Mednick, S.A. 1999: MMPI variables predictive of schizophrenia in the Copenhagen High-Risk Project: A 25-year follow-up. Acta Psychiatrica Scandinavica 99(6): 432-440
Baldrachi, R.; Hilsenroth, M.; Arsenault, L.; Sloan, P.; Walter, C. 1999: MMPI-2 assessment of varying levels of posttraumatic stress in Vietnam combat veterans. Journal of Psychopathology and Behavioral Assessment 21(2): 109-116
Forbes, D.; Creamer, M.; Allen, N.; Elliott, P.; McHugh, T.; Debenham, P.; Hopwood, M. 2003: MMPI-2 based subgroups of veterans with combat-related PTSD: differential patterns of symptom change after treatment. Journal of Nervous and Mental Disease 191(8): 531-537
Strassberg, D.S.; Russell, S.W. 2000: MMPI-2 content scale validity within a sample of chronic pain patients. Journal of Psychopathology and Behavioral Assessment 22(1): 47-60
Mongini, F.; Ibertis, F.; Barbalonga, E.; Raviola, F. 2000: MMPI-2 profiles in chronic daily headache and their relationship to anxiety levels and accompanying symptoms. Headache 40(6): 466-472
Müller-Ladner, U.; Gay, S. 2002: MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction?. Annals of the Rheumatic Diseases 61(11): 957-959
Schuppan, D.; Hahn, E.G. 2000: MMPs in the gut: inflammation hits the matrix. Gut 47(1): 12-14
Marcq, Vérie.; Mirand, C.; Decarme, M.; Emonard, Hé.; Hornebeck, W. 2003: MMPs inhibitors: New succinylhydroxamates with selective inhibition of MMP-2 over MMP-3. Bioorganic and Medicinal Chemistry Letters 13(17): 2843-2846
Farrington, C.P.; Miller, E.; Taylor, B. 2001: MMR and autism: further evidence against a causal association. Vaccine 19(27): 3632-3635
Ramsay, M.; White, J.; Crowcroft, N. 2002: MMR uptake data are unlikely to be subject to manipulation. Bmj 324(7350): 1394
Schmidt, K.; Ernst, E. 2003: MMR vaccination advice over the Internet. Vaccine 21(11-12): 1044-1047
Lakshman, R.; Finn, A. 2000: MMR vaccine and allergy. Archives of Disease in Childhood 82(2): 93-95
Black, C.; Kaye, J.A.; Jick, H. 2003: MMR vaccine and idiopathic thrombocytopaenic purpura. British Journal of Clinical Pharmacology 55(1): 107-111
Fry, R. 2002: MMR vaccine debate. Debate crystallises dilemma facing many medical disciplines. Bmj 324(7339): 733-734
Goon, P.; Cohen, B.; Jin, L.; Watkins, R.; Tudor-Williams, G. 2001: MMR vaccine in HIV-infected children -- potential hazards?. Vaccine 19(28-29): 3816-3819
Scanlon, T.J. 2002: MMR vaccine uptake may be lower than reported because of manipulation of target groups. Bmj 324(7339): 733
Hryciw, T.; Tang, M.; Fontanie, T.; Xiao, W. 2002: MMS1 protects against replication-dependent DNA damage in Saccharomyces cerevisiae. Molecular Genetics and Genomics: Mgg 266(5): 848-857
Daphna Iken, D.; Shankar, D.B.; Lawshe, A.; Ornitz, D.M.; Shackleford, G.M.; Macarthur, C.A. 1998: MMTV-Fgfdelta transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene 17(21): 2711-2717
Ouatas, T.; Clare, S.E.; Hartsough, M.T.; De La Rosa, A.; Steeg, P.S. 2002: MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines. Clinical and Experimental Metastasis 19(1): 35-42
Murakami, Y.; Kanda, K.; Tsuji, M.; Kanayama, H.; Kagawa, S. 1999: MN/CA9 gene expression as a potential biomarker in renal cell carcinoma. BJU International 83(7): 743-747
Carter, J.; Finn, J.T. 1999: MOAB: A spatially explicit, individual-based expert system for creating animal foraging models. Ecological Modelling 119(1): 29-41
Morgan, R.L.; De Young, B.R.; McGaughy, V.R.; Niemann, T.H. 1999: MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells. Cancer 87(6): 390-394
Niemann, T.H.; Hughes, J.H.; De Young, B.R. 1999: MOC-31 aids in the differentiation of metastatic adenocarcinoma from hepatocellular carcinoma. Cancer 87(5): 295-298
Proca, D.M.; Niemann, T.H.; Porcell, A.I.; DeYoung, B.R. 2000: MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers. Applied Immunohistochemistry and Molecular Morphology: Aimm 8(2): 120-125
Mcclain, C.R.; Fougerolle, M.F.; Rex, M.A.; Welch, J. 2001: MOCNESS estimates of the size and abundance of a pelagic gonostomatid fish Cyclothone pallida off the Bahamas. Journal of the: 869-871
Loubradou, G.; Bégueret, J.; Turcq, B. 1999: MOD-D, a Galpha subunit of the fungus Podospora anserina, is involved in both regulation of development and vegetative incompatibility. Genetics 152(2): 519-528
Bergez, J.E.; Debaeke, P.; Deumier, J.M.; Lacroix, B.; Leenhardt, D.; Leroy, P.; Wallach, D. 2001: MODERATO: An object-oriented decision tool for designing maize irrigation schedules. Ecological Modelling 137(1): 43-60, 1 February
Drouet, J.L. 2003: MODICA and MODANCA: Modelling the three-dimensional shoot structure of graminaceous crops from two methods of plant description. Field Crops Research 83(2): 215-222, 20 August
Dani, V.S.; Ramakrishnan, C.; Varadarajan, R. 2003: MODIP revisited: re-evaluation and refinement of an automated procedure for modeling of disulfide bonds in proteins. Protein Engineering 16(3): 187-193
Gitelson, A.A.; Kaufman, Y.J. 1998: MODIS NDVI optimization to fit the AVHRR data series: Spectral considerations. Remote Sensing of Environment 66(3): 343-350
Van Leeuwen, W.J.D.; Huete, A.R.; Laing, T.W. 1999: MODIS vegetation index compositing approach: A prototype with AVHRR data. Remote Sensing of Environment 69(3): 264-280
Kristinsson, S.Y.; Thorolfsdottir, E.T.; Talseth, B.; Steingrimsson, E.; Thorsson, A.V.; Helgason, T.; Hreidarsson, A.B.; Arngrimsson, R. 2001: MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. Diabetologia 44(11): 2098-2103
Jankovics, F.; Sinka, R.; Lukácsovich, Tás.; Erdélyi, Mós. 2002: MOESIN crosslinks actin and cell membrane in Drosophila oocytes and is required for OSKAR anchoring. Current Biology: Cb 12(23): 2060-2065
Buscaino, A.; Köcher, T.; Kind, J.H.; Holz, H.; Taipale, M.; Wagner, K.; Wilm, M.; Akhtar, A. 2003: MOF-regulated acetylation of MSL-3 in the Drosophila dosage compensation complex. Molecular Cell 11(5): 1265-1277
Sun, H.; Li, M.; Xu, Y. 2003: MOLVIE: An interactive visualization environment for molecular structures. Computer Methods and Programs in Biomedicine 71(1): 85-90
Shin, T.H.; Yasuda, J.; Rocheleau, C.E.; Lin, R.; Soto, M.; Bei, Y.; Davis, R.J.; Mello, C.C. 1999: MOM-4, a MAP kinase kinase kinase-related protein, activates WRM-1/LIT-1 kinase to transduce anterior/posterior polarity signals in C. elegans. Molecular Cell 4(2): 275-280
Labesse, G.; Garnotel, E.; Bonnel, S.; Dumas, C.; Pages, J.M.; Bolla, J.M. 2001: MOMP, a divergent porin from Campylobacter: cloning and primary structural characterization. Biochemical and Biophysical Research Communications 280(1): 380-387
Salerni, Elena; Lagana, Angela; Perini, Claudia; De-Dominicis, Vincenzo 1999: MON.I.TO: Intensive monitoring of forests in Toscana. Micologia Italiana 28(3): 19-28
Hitchens, T.Kevin.; Lukin, J.A.; Zhan, Y.; McCallum, S.A.; Rule, G.S. 2003: MONTE: An automated Monte Carlo based approach to nuclear magnetic resonance assignment of proteins. Journal of Biomolecular NMR 25(1): 1-9
Spike, R.C.; Puskár, Z.; Sakamoto, H.; Stewart, W.; Watt, C.; Todd, A.J. 2002: MOR-1-immunoreactive neurons in the dorsal horn of the rat spinal cord: Evidence for nonsynaptic innervation by substance P-containing primary afferents and for selective activation by noxious thermal stimuli. European Journal of Neuroscience 15(8): 1306-1316
Ray, J.G.; Burrows, R.F.; Burrows, E.A.; Vermeulen, M.J. 2001: MOS HIP: McMaster outcome study of hypertension in pregnancy. Early Human Development 64(2): 129-143
Daeppen, J.B.; Krieg, M.A.; Burnand, B.; Yersin, B. 1998: MOS-SF-36 in evaluating health-related quality of life in alcohol-dependent patients. American Journal of Drug and Alcohol Abuse 24(4): 685-694
Nabavi, D.G.; Kloska, S.P.; Nam, E-Mi.; Freund, M.; Gaus, C.G.; Klotz, E.; Heindel, W.; Ringelstein, E.Bernd. 2002: MOSAIC: Multimodal Stroke Assessment Using Computed Tomography: novel diagnostic approach for the prediction of infarction size and clinical outcome. Stroke 33(12): 2819-2826
André, C.; Vincens, P.; Boisvieux, J.F.; Hazout, S. 2001: MOSAIC: segmenting multiple aligned DNA sequences. Bioinformatics 17(2): 196-197
Ueno, Y.; Asai, K. 2002: MOSBY: A molecular structure viewer program with portability and extensibility. Journal of Molecular Graphics and Modelling 20(5): 411-413
Anantharaman, V.; Aravind, L. 2002: MOSC domains: ancient, predicted sulfur-carrier domains, present in diverse metal-sulfur cluster biosynthesis proteins including Molybdenum cofactor sulfurases. FEMS Microbiology Letters 207(1): 55-61
Ried, S.; Specht, U.; Thorbecke, R.; Goecke, K.; Wohlfarth, R. 2001: MOSES: An educational program for patients with epilepsy and their relatives. Epilepsia 42(Suppl): 76-80
Cheung, T.; Butson, M.J.; Yu, P.K.N. 2003: MOSFET dosimetry in-vivo at superficial and orthovoltage x-ray energies. Australasian Physical and Engineering Sciences in Medicine 26(2): 82-84
Flessa, S. 2001: MOSHI: a culture-tailored management game for African hospital managers. Tropical Doctor 31(3): 144-146
Muldrow, T.A.; Campbell, A.M.; Weil, P.A.; Auble, D.T. 1999: MOT1 can activate basal transcription in vitro by regulating the distribution of TATA binding protein between promoter and nonpromoter sites. Molecular and Cellular Biology 19(4): 2835-2845
Darst, R.P.; Wang, D.; Auble, D.T. 2001: MOT1-catalyzed TBP-DNA disruption: uncoupling DNA conformational change and role of upstream DNA. EMBO Journal 20(8): 2028-2040
Burckhardt, F. 2002: MOUSE (Mitochondrial and Other Useful SEquences) a compilation of population genetic markers. Bioinformatics 18(6): 890-891
Chaffanet, M.; Gressin, L.; Preudhomme, C.; Soenen-Cornu, V.; Birnbaum, D.; Pébusque, M.J. 2000: MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes and Cancer 28(2): 138-144
Deguchi, K.; Ayton, P.M.; Carapeti, M.; Kutok, J.L.; Snyder, C.S.; Williams, I.R.; Cross, N.C.P.; Glass, C.K.; Cleary, M.L.; Gilliland, D.Gary. 2003: MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 3(3): 259-271
Karlowski, W.M.; Schoof, H.; Janakiraman, V.; Stuempflen, V.; Mayer, K.F.X. 2003: MOsDB: an integrated information resource for rice genomics. Nucleic Acids Research 31(1): 190-192
Gonen, T.; Grey, A.C.; Jacobs, M.D.; Donaldson, P.J.; Kistler, J. 2001: MP20, the second most abundant lens membrane protein and member of the tetraspanin superfamily, joins the list of ligands of galectin-3. Bmc Cell Biology 2: 17
Poepping, T.L.; Gill, J.; Fenster, A.; Holdsworth, D.W. 2003: MP3 compression of Doppler ultrasound signals. Ultrasound in Medicine and Biology 29(1): 65-76
Vandegriff, K.D.; Malavalli, A.; Wooldridge, J.; Lohman, J.; Winslow, R.M. 2003: MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 43(4): 509-516
Florio, S.; Crispino, L.; Ciarcia, R.; Vacca, G.; Pagnini, U.; de Matteis, A.; Pacilio, C.; D'Andrilli, G.; Kumar, C.; Giordano, A. 2003: MPA increases idarubicin-induced apoptosis in chronic lymphatic leukaemia cells via caspase-3. Journal of Cellular Biochemistry 89(4): 747-754
Fujii, R.; Ishikawa, H.; Mahmoud, M.S.; Asaoku, H.; Kawano, M.M. 1999: MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas. British Journal of Haematology 105(1): 131-140
Schenk, B.; Imbach, T.; Frank, C.G.; Grubenmann, C.E.; Raymond, G.V.; Hurvitz, H.; Korn-Lubetzki, I.; Revel-Vik, S.; Raas-Rotschild, A.; Luder, A.S.; Jaeken, J.; Berger, E.G.; Matthijs, G.; Hennet, T.; Aebi, M. 2001: MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. Journal of Clinical Investigation 108(11): 1687-1695
Zambaux, M.F.; Bonneaux, F.; Gref, R.; Dellacherie, E.; Vigneron, C. 1999: MPEO-PLA nanoparticles: Effect of MPEO content on some of their surface properties. Journal of Biomedical Materials Research 44(1): 109-115
Schachtman, T.R.; Bills, C.; Ghinescu, R.; Murch, K.; Serfozo, P.; Simonyi, A. 2003: MPEP, a selective metabotropic glutamate receptor 5 antagonist, attenuates conditioned taste aversion in rats. Behavioural Brain Research 141(2): 177-182
Karaïskou, A.; Cayla, X.; Haccard, O.; Jessus, C.; Ozon, R. 1998: MPF amplification in Xenopus oocyte extracts depends on a two-step activation of cdc25 phosphatase. Experimental Cell Research 244(2): 491-500
Magen, D.; Mandel, H.; Berant, M.; Ben-Izhak, O.; Zelikovic, I. 2002: MPGN type i induced by granulocyte colony stimulating factor. Pediatric Nephrology 17(5): 370-372
Govindarajan, K.Ramamoorthy.; Kangueane, P.; Tan, T.Wee.; Ranganathan, S. 2003: MPID: MHC-Peptide Interaction Database for sequence-structure-function information on peptides binding to MHC molecules. Bioinformatics 19(2): 309-310
Gil, M.; Yang, Y.; Ha, H. 1998: MPK38 expression is upregulated in immature T cells activated by concanavalin A. Immunology Letters 64(2-3): 79-83
Maytal-Kivity, V.; Reis, N.; Hofmann, K.; Glickman, M.H. 2002: MPN+, a putative catalytic motif found in a subset of MPN domain proteins from eukaryotes and prokaryotes, is critical for Rpn11 function. Bmc Biochemistry 3: 28
Reynolds, W.F.; Hiltunen, M.; Pirskanen, M.; Mannermaa, A.; Helisalmi, S.; Lehtovirta, M.; Alafuzoff, I.; Soininen, H. 2000: MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males. Neurology 55(9): 1284-1290
Wong, R.C.; Field, K. 2001: MPO-ANCA may produce a combination of P-ANCA and atypical cytoplasmic ANCA indirect immunofluorescent patterns on certain ethanol fixed neutrophil substrates. Journal of Clinical Pathology 54(4): 335
Keven, K.; Akar, H.; Kutlay, S.; Nergizoglu, G.; Erbay, B.; Erturk, S. 2002: MPO-ANCA-associated pulmonary-renal vasculitis in a patient with diabetes mellitus. Journal of Nephrology 15(6): 720-723
Akar, H.; Ozbasli-Levi, C.; Senturk, T.; Kadikoylu, G.; Levi, E.; Bolaman, Z. 2002: MPO-ANCA-associated small vessel vasculitis presenting as fever of unknown origin. Report of one case. Nephron 92(3): 673-675
Aoyama, T.; Shimizu, T.; Matsuo, T.; Sakamoto, H.; Kamata, K.; Higashihara, M.; Tsuji, H.; Shigematsu, H.; Kobayashi, Y. 2002: MPO-ANCA-positive slowly progressive glomerulonephritis with focal tuft necrosis and crescents. Internal Medicine 41(6): 458-462
Olazábal, D.E.; Kalinichev, M.; Morrell, J.I.; Rosenblatt, J.S. 2002: MPOA cytotoxic lesions and maternal behavior in the rat: effects of midpubertal lesions on maternal behavior and the role of ovarian hormones in maturation of MPOA control of maternal behavior. Hormones and Behavior 41(2): 126-138
Fall, C.P.; Bennett, J.P. 1998: MPP+ induced SH-SY5Y apoptosis is potentiated by cyclosporin A and inhibited by aristolochic acid. Brain Research 811(1-2): 143-146
Kim, H.E.; Yoon, S.Y.; Lee, J.E.; Choi, W.S.; Jin, B.K.; Oh, T.H.; Markelonis, G.J.; Chun, S.Y.; Oh, Y.J. 2001: MPP(+) downregulates mitochondrially encoded gene transcripts and their activities in dopaminergic neuronal cells: protective role of Bcl-2. Biochemical and Biophysical Research Communications 286(3): 659-665
Gómez-Santos, C.; Ferrer, I.; Reiriz, J.; Viñals, F.; Barrachina, M.; Ambrosio, S. 2002: MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Research 935(1-2): 32-39
Lee, H.S.; Park, C.W.; Kim, Y.S. 2000: MPP(+) increases the vulnerability to oxidative stress rather than directly mediating oxidative damage in human neuroblastoma cells. Experimental Neurology 165(1): 164-171
Soldner, F.; Weller, M.; Haid, S.; Beinroth, S.; Miller, S.W.; Wüllner, U.; Davis, R.E.; Dichgans, J.; Klockgether, T.; Schulz, J.B. 1999: MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1). Experimental Cell Research 250(1): 75-85
Canudas, A.M.; Friguls, B.; Planas, A.M.; Gabriel, C.; Escubedo, E.; Camarasa, J.; Camins, A.; Pallàs, M. 2000: MPP(+) injection into rat substantia nigra causes secondary glial activation but not cell death in the ipsilateral striatum. Neurobiology of Disease 7(4): 343-361
Boada, J.; Cutillas, B.; Roig, T.; Bermúdez, J.; Ambrosio, S. 2000: MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine. Biochemical and Biophysical Research Communications 268(3): 916-920
Blanchet, C.; Combet, C.; Geourjon, C.; Deléage, G. 2000: MPSA: integrated system for multiple protein sequence analysis with client/server capabilities. Bioinformatics 16(3): 286-287
Saporito, M.S.; Thomas, B.A.; Scott, R.W. 2000: MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. Journal of Neurochemistry 75(3): 1200-1208
Grünblatt, E.; Mandel, S.; Youdim, M.B. 2000: MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: Neuroprotective strategies. Journal of Neurology 247(Suppl): Ii95
Rojas, P.; Rojas-Castañeda, J.; Vigueras, R.M.; Habeebu, S.S.; Rojas, C.; Ríos, C.; Ebadi, M. 2000: MPTP decreases MT-I mRNA in mouse striatum. Neurochemical Research 25(4): 503-509
Kowall, N.W.; Hantraye, P.; Brouillet, E.; Beal, M.F.; McKee, A.C.; Ferrante, R.J. 2000: MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport 11(1): 211-213
Fernandez-Gonzalez, A.; Pérez-Otaño, I.; Morgan, J.I. 2000: MPTP selectively induces haem oxygenase-1 expression in striatal astrocytes. European Journal of Neuroscience 12(5): 1573-1583
Sedelis, M.; Hofele, K.; Auburger, G.W.; Morgan, S.; Huston, J.P.; Schwarting, R.K. 2000: MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behavior Genetics 30(3): 171-182
Mikkelsen, M.; Møller, A.; Jensen, L.H.; Pedersen, A.; Harajehi, J.B.; Pakkenberg, H. 1999: MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological study. Neurotoxicology and Teratology 21(2): 169-175
Zhang, Z.; Zhang, M.; Ai, Y.; Avison, C.; Gash, D.M. 1999: MPTP-Induced pallidal lesions in rhesus monkeys. Experimental Neurology 155(1): 140-149
Shimoke, K.; Kudo, M.; Ikeuchi, T. 2003: MPTP-induced reactive oxygen species promote cell death through a gradual activation of caspase-3 without expression of GRP78/Bip as a preventive measure against ER stress in PC12 cells. Life Sciences 73(5): 581-593
Speciale, S.G. 2002: MPTP: Insights into parkinsonian neurodegeneration. Neurotoxicology and Teratology 24(5): 607-620
Jayasinghe, S.; Hristova, K.; White, S.H. 2001: MPtopo: a database of membrane protein topology. Protein Science: a Publication of the Protein Society 10(2): 455-458
Yan, J.; Corpora, T.; Pradhan, P.; Bushweller, J.H. 2002: MQ-hCN-based pulse sequences for the measurement of 13C1'-1H1', 13C1'-15N, 1H1'-15N, 13C1'-13C2', 1H1'-13C2',13C6/8-1H6/8, 13C6/8-15N, 1H6/8-15N, 13C6-13C5, 1H6-13C5 dipolar couplings in 13C, 15N-labeled DNA (and RNA). Journal of Biomolecular NMR 22(1): 9-20
Auvray, P.; Sourdaine, P.; Moslemi, S.; Séralini, G.E.; Sonnet, P.; Enguehard, C.; Guillon, J.; Dallemagne, P.; Bureau, R.; Rault, S. 1999: MR 20492 and MR 20494: Two indolizinone derivatives that strongly inhibit human aromatase. Journal of Steroid Biochemistry and Molecular Biology 70(1-3): 59-71
Maas, M.; Slim, E.J.; Heoksma, A.F.; van der Kleij, A.J.; Akkerman, E.M.; den Heeten, G.J.; Faber, W.R. 2002: MR imaging of neuropathic feet in leprosy patients with suspected osteomyelitis. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 70(2): 97-103
Yang, X.; Pernu, H.; Pyhtinen, J.; Tiilikainen, P.A.; Oikarinen, Kösti.S.; Raustia, A.M. 2002: MR abnormalities of the lateral pterygoid muscle in patients with nonreducing disk displacement of the TMJ. Cranio: the Journal of Craniomandibular Practice 20(3): 209-221
Nakada, T. 1999: MR analysis of brain function. No to Hattatsu 31(3): 212-216
Yousry, I.; Moriggl, B.; Dieterich, M.; Naidich, T.P.; Schmid, U.D.; Yousry, T.A. 2002: MR anatomy of the proximal cisternal segment of the trochlear nerve: neurovascular relationships and landmarks. Radiology 223(1): 31-38
Rofsky, N.M.; Adelman, M.A. 2000: MR angiography in the evaluation of atherosclerotic peripheral vascular disease. Radiology 214(2): 325-338
Morimoto, A.; Yoshimura, H.; Hosokawa, C.; Yoshida, T. 2000: MR angiography of hemodialysis access fistula: evaluation before PTA procedure. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 60(9): 526-528
Kominami, M.; Yamada, N.; Imakita, S.; Uchida, R.; Kuribayashi, S.; Kimura, K.; Takamiya, M. 1999: MR angiography of steno-occlusive lesions of intracranial arteries: a comparative study between turbo MRA and conventional MRA. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 59(11): 504-509
Krause, U.; Pabst, T.; Kenn, W.; Wittenberg, G.; Hahn, D. 2001: MR angiography of the hand arteries. Angiology 52(11): 763-772
Liauw, L.; van Buchem, M.A.; Spilt, A.; de Bruïne, F.T.; van den Berg, R.; Hermans, J.; Wasser, M.N. 2000: MR angiography of the intracranial venous system. Radiology 214(3): 678-682
Azhari, H.; Mckenzie, C.A.; Edelman, R.R. 2001: MR angiography using spin-lock flow tagging. Magnetic Resonance in Medicine 46(5): 1041-1044
Foo, T.K.F.; Ho, V.B.; Marcos, H.B.; Hood, M.N.; Choyke, P.L. 2002: MR angiography using steady-state free precession. Magnetic Resonance in Medicine 48(4): 699-706
Ruehm, S.G.; Christina, H.; Violas, X.; Corot, C.; Debatin, J.ör.F. 2002: MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits. Magnetic Resonance in Medicine 48(5): 844-851
Schmitz, S.A.; Albrecht, T.; Wolf, K.J. 1999: MR angiography with superparamagnetic iron oxide: feasibility study. Radiology 213(2): 603-607
Kähärä, V.J.; Seppänen, S.K.; Ryymin, P.S.; Mattila, P.; Kuurne, T.; Laasonen, E.M. 1999: MR angiography with three-dimensional time-of-flight and targeted maximum-intensity-projection reconstructions in the follow-up of intracranial aneurysms embolized with Guglielmi detachable coils. Ajnr. American Journal of Neuroradiology 20(8): 1470-1475
Laissy, J.P.; Trillaud, H.; Douek, P. 2002: MR angiography: noninvasive vascular imaging of the abdomen. Abdominal Imaging 27(5): 488-506
Venkatesh, S.K.; Phadke, R.V.; Kumar, S.; Mishra, U.K. 2003: MR appearance of interpeduncular lipoma. Singapore Medical Journal 44(1): 39-41
Razek, A.A.; Elasfour, A.A. 1999: MR appearance of rhinoscleroma. Ajnr. American Journal of Neuroradiology 20(4): 575-578
Sugimoto, H.; Suzuki, K.; Mihara, K-ichi.; Kubota, H.; Tsutsui, H. 2002: MR arthrography of shoulders after suture-anchor Bankart repair. Radiology 224(1): 105-111
Mummaneni, P.V.; Simon, E.M.; Peacock, W.J.; Barkovich, A.J. 1999: MR artifact mimicking a temporal lobe lesion in an epilepsy patient. Pediatric Neurosurgery 30(4): 203-205
Greer, P.J.; Villemagne, V.L.; Ruszkiewicz, J.; Graves, A.K.; Meltzer, C.Cidis.; Mathis, C.A.; Price, J.C. 2002: MR atlas of the baboon brain for functional neuroimaging. Brain Research Bulletin 58(4): 429-438
Huisman, T.A.G.M.; Wisser, J.; Stallmach, T.; Krestin, G.P.; Huch, R.; Kubik-Huch, R.A. 2002: MR autopsy in fetuses. Fetal Diagnosis and Therapy 17(1): 58-64
Krings, T.; Erberich, S.G.; Roessler, F.; Reul, J.; Thron, A. 1999: MR blood oxygenation level-dependent signal differences in parenchymal and large draining vessels: implications for functional MR imaging. Ajnr. American Journal of Neuroradiology 20(10): 1907-1914
Seifert, T.; Giacomini, G.; Kapeller, P.; Fazekas, F. 2002: MR brain changes following terpentine oil ingestion. Journal of Neurology 249(8): 1109-1110
Galluzzi, P.; Rufa, A.; Balestri, P.; Cerase, A.; Federico, A. 2001: MR brain imaging of fucosidosis type I. Ajnr. American Journal of Neuroradiology 22(4): 777-780
Kulkarni, A.V.; Armstrong, D.C.; Drake, J.M. 1999: MR characteristics of malignant spinal cord astrocytomas in children. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 26(4): 290-293
Bhatti, M.T.; Holder, C.A.; Newman, N.J.; Hudgins, P.A. 2000: MR characteristics of muslin-induced optic neuropathy: report of two cases and review of the literature. Ajnr. American Journal of Neuroradiology 21(2): 346-352
Yamada, Y. 1999: MR characterization of blood flow in coronary artery bypass grafts. Dokkyo Journal of Medical Sciences 26(1): 83-88
Kim, J.Hee.; Kim, M-Jin.; Park, S.Il.; Chung, J-Joon.; Song, S.Young.; Kim, K.Sik.; Yoo, H.Sik.; Lee, J.Tae.; Kim, K.Whang. 2002: MR cholangiography in symptomatic gallstones: diagnostic accuracy according to clinical risk group. Radiology 224(2): 410-416
Jaw, T.S.; Kuo, Y.T.; Liu, G.C.; Chen, S.H.; Wang, C.K. 1999: MR cholangiography in the evaluation of neonatal cholestasis. Radiology 212(1): 249-256
Norton, K.I.; Glass, R.B.; Kogan, D.; Lee, J.S.; Emre, S.; Shneider, B.L. 2002: MR cholangiography in the evaluation of neonatal cholestasis: initial results. Radiology 222(3): 687-691
Little, A.F.; Lee, W.K.; Mathison, K. 2002: MR cholangiography in the evaluation of suspected intrabiliary rupture of hepatic hydatid cyst. Abdominal Imaging 27(3): 333-335
Naganawa, S.; Koshikawa, T.; Fukatsu, H.; Ishigaki, T.; Fukuta, T. 2001: MR cisternography of the cerebellopontine angle: comparison of three-dimensional fast asymmetrical spin-echo and three-dimensional constructive interference in the steady-state sequences. Ajnr. American Journal of Neuroradiology 22(6): 1179-1185
Lauenstein, T.C.; Goehde, S.C.; Ruehm, S.G.; Holtmann, G.; Debatin, Jörg.F. 2002: MR colonography with barium-based fecal tagging: initial clinical experience. Radiology 223(1): 248-254
Martin, D.R.; Yang, M.; Thomasson, D.; Acheson, C. 2002: MR colonography: development of optimized method with ex vivo and in vivo systems. Radiology 225(2): 597-602
Luboldt, W.; Frohlich, J.M.; Schneider, N.; Weishaupt, D.; Landolt, F.; Debatin, J.F. 1999: MR colonography: optimized enema composition. Radiology 212(1): 265-269
Luboldt, W.; Morrin, M.M. 2002: MR colonography: Status and perspective. Abdominal Imaging 27(4): 400-409
Breslau, J.; Jarvik, J.G.; Haynor, D.R.; Longstreth, W.T.; Kent, D.L.; Maravilla, K.R. 1999: MR contrast media in neuroimaging: a critical review of the literature. Ajnr. American Journal of Neuroradiology 20(4): 670-675
van Geuns, R.J.; Wielopolski, P.A.; de Bruin, H.G.; Rensing, B.J.; Hulshoff, M.; van Ooijen, P.M.; de Feyter, P.J.; Oudkerk, M. 2000: MR coronary angiography with breath-hold targeted volumes: preliminary clinical results. Radiology 217(1): 270-277
Bunce, N.H.; Lorenz, C.H.; Pennell, D.J. 2001: MR coronary angiography: 2001 update. Rays 26(1): 61-69
De Stefano, N.; Iannucci, G.; Sormani, M.P.; Guidi, L.; Bartolozzi, M.L.; Comi, G.; Federico, A.; Filippi, M. 2002: MR correlates of cerebral atrophy in patients with multiple sclerosis. Journal of Neurology 249(8): 1072-1077
Manfrè, L.; de Maria, M.; Todaro, E.; Mangiameli, A.; Ponte, F.; Lagalla, R. 2000: MR dacryocystography: comparison with dacryocystography and CT dacryocystography. AJNR. American Journal of Neuroradiology 21(6): 1145-1150
Sasaki, T.; Saito, Y.; Yodono, H.; Miura, H.; Shinohara, A.; Mizuno, K.; Abe, S.; Itabashi, Y.; Kawashima, S.; Nakano, K.; Nishiya, M. 1998: MR diagnosis of internal derangement of the knee by SE T1 and GRE T2* weighted images: evaluation of 300 arthroscopically proven knees. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 58(11): 572-577
Nucifora, P.G.; Dillon, W.P. 2001: MR diagnosis of myxomatous aneurysms: report of two cases. Ajnr. American Journal of Neuroradiology 22(7): 1349-1352
Le Bars, E.; Gondry-Jouet, C.; Deramond, H.; Le Gars, D.; Idy-Peretti, I. 2000: MR diffusion and perfusion imaging in clinical practice. Journal of Neuroradiology 27(1): 39-51
Tsuchiya, K.; Katase, S.; Yoshino, A.; Hachiya, J. 2000: MR digital subtraction angiography of cerebral arteriovenous malformations. Ajnr. American Journal of Neuroradiology 21(4): 707-711
Chakravarty, A. 2003: MR evaluation of crossed and uncrossed cerebral-cerebellar diaschisis. Acta Neurologica Scandinavica 108(1): 60-65
Ross, J.S.; Obuchowski, N.; Modic, M.T. 1999: MR evaluation of epidural fibrosis: proposed grading system with intra- and inter-observer variability. Neurological Research 21 Suppl. 1: S23-S26
Sato, N.; Hatakeyama, S.; Shimizu, N.; Hikima, A.; Aoki, J.; Endo, K. 2001: MR evaluation of the hippocampus in patients with congenital malformations of the brain. Ajnr. American Journal of Neuroradiology 22(2): 389-393
Barkhausen, J.; Ruehm, S.G.; Goyen, M.; Buck, T.; Laub, G.; Debatin, J.F. 2001: MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology 219(1): 264-269
Davidson, H.C.; Harnsberger, H.R.; Lemmerling, M.M.; Mancuso, A.A.; White, D.K.; Tong, K.A.; Dahlen, R.T.; Shelton, C. 1999: MR evaluation of vestibulocochlear anomalies associated with large endolymphatic duct and sac. Ajnr. American Journal of Neuroradiology 20(8): 1435-1441
Chong, J.; Di Rocco, A.; Tagliati, M.; Danisi, F.; Simpson, D.M.; Atlas, S.W. 1999: MR findings in AIDS-associated myelopathy. Ajnr. American Journal of Neuroradiology 20(8): 1412-1416
Chu, B.C.; Terae, S.; Hida, K.; Furukawa, M.; Abe, S.; Miyasaka, K. 2001: MR findings in spinal hemangioblastoma: correlation with symptoms and with angiographic and surgical findings. Ajnr. American Journal of Neuroradiology 22(1): 206-217
Ilniczky, S.; Jelencsik, I.; Kenéz, J.; Szirmai, I. 2002: MR findings in subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia--two cases. European Journal of Neurology 9(1): 101-104
Song, I.S.; Yang, S.J. 2001: MR findings of flexor hallucis longus tendinitis in ballet dancers. Chung-Ang Journal of Medicine 26(2): 83-88
Shakudo, M. 1999: MR findings of intramedullary tumors. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 59(11): 491-495
Shin, J.Y.; Lee, S.M.; Hwang, M.Y.; Sohn, C.H.; Suh, S.J. 2001: MR findings of the spinal paraganglioma : report of three cases. Journal of Korean Medical Science 16(4): 522-526
Langerak, S.E.; Kunz, P.; Vliegen, H.W.; Jukema, J.Wouter.; Zwinderman, A.H.; Steendijk, P.; Lamb, H.J.; van der Wall, E.E.; de Roos, A. 2002: MR flow mapping in coronary artery bypass grafts: a validation study with Doppler flow measurements. Radiology 222(1): 127-135
Rasche, V.; Holz, D.; Proksa, R. 1999: MR fluoroscopy using projection reconstruction multi-gradient-echo (prMGE) MRI. Magnetic Resonance in Medicine 42(2): 324-334
Sze, D.Y.; Mackey, S.C. 2002: MR guidance of sympathetic nerve blockade: measurement of vasomotor response initial experience in seven patients. Radiology 223(2): 574-580
Lee, B.C.; Vo, K.D.; Kido, D.K.; Mukherjee, P.; Reichenbach, J.; Lin, W.; Yoon, M.S.; Haacke, M. 1999: MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. Ajnr. American Journal of Neuroradiology 20(7): 1239-1242
Ohgi, K.; Toyoda, M.; Yokote, H.; Kobori, K.; Furukawa, T. 2001: MR hydrography of the abdomen: technical consideration of data acquisition and future prospects for clinical applications. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 61(5): 215-221
Heverhagen, J.T.; Müller, D.; Battmann, A.; Ishaque, N.; Boehm, D.; Katschinski, M.; Wagner, H.J.; Klose, K.J. 2001: MR hydrometry to assess exocrine function of the pancreas: initial results of noninvasive quantification of secretion. Radiology 218(1): 61-67
Ledermann, H.Peter.; Morrison, W.B.; Schweitzer, M.E. 2002: MR image analysis of pedal osteomyelitis: distribution, patterns of spread, and frequency of associated ulceration and septic arthritis. Radiology 223(3): 747-755
Lundbom, N.; Barnett, A.; Bonavita, S.; Patronas, N.; Rajapakse, J.; Tedeschi; Di Chiro, G. 1999: MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain. Magnetic Resonance in Medicine 41(4): 841-845
Brown, M.A.; Semelka, R.C. 1999: MR imaging abbreviations, definitions, and descriptions: a review. Radiology 213(3): 647-662
Kivisaari, R.P.; Salonen, O.; Servo, A.; Autti, T.; Hernesniemi, J.; Ohman, J. 2001: MR imaging after aneurysmal subarachnoid hemorrhage and surgery: a long-term follow-up study. Ajnr. American Journal of Neuroradiology 22(6): 1143-1148
Naegele, T.; Grodd, W.; Viebahn, R.; Seeger, U.; Klose, U.; Seitz, D.; Kaiser, S.; Mader, I.; Mayer, J.; Lauchart, W.; Gregor, M.; Voigt, K. 2000: MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 216(3): 683-691
Imamura, A.; Orii, K.E.; Mizuno, S.; Hoshi, H.; Kondo, T. 2002: MR imaging and 1H-MR spectroscopy in a case of juvenile Alexander disease. Brain and Development 24(7): 723-726
Manfredi, R.; Masselli, G.; Maresca, G.; Brizi, M.G.; Vecchioli, A.; Marano, P. 2003: MR imaging and MRCP of hilar cholangiocarcinoma. Abdominal Imaging 28(3): 319-325
Deryani, E.; Aki, S.; Muslumanoglu, L.; Rozanes, I. 2003: MR imaging and electrophysiological evaluation in carpal tunnel syndrome. Yonsei Medical Journal 44(1): 27-32
Castillo, M.; Morrison, T.; Shaw, J.A.; Bouldin, T.W. 2001: MR imaging and histologic features of capillary telangiectasia of the basal ganglia. Ajnr. American Journal of Neuroradiology 22(8): 1553-1555
Song, C.J.; Kim, J.H.; Kier, E.L.; Bronen, R.A. 2000: MR imaging and histologic features of subinsular bright spots on T2-weighted MR images: Virchow-Robin spaces of the extreme capsule and insular cortex. Radiology 214(3): 671-677
Bowen, B.C.; Pattany, P.M.; Bradley, W.G.; Murdoch, J.B.; Rotta, F.; Younis, A.A.; Duncan, R.C.; Quencer, R.M. 2000: MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. Ajnr. American Journal of Neuroradiology 21(4): 647-658
Farina, L.; Bizzi, A.; Finocchiaro, G.; Pareyson, D.; Sghirlanzoni, A.; Bertagnolio, B.; Savoiardo, M.; Naidu, S.; Singhal, B.S.; Wenger, D.A. 2000: MR imaging and proton MR spectroscopy in adult Krabbe disease. Ajnr. American Journal of Neuroradiology 21(8): 1478-1482
Floeth, F.W.; Aulich, A.; Langen, K.J.; Burger, K.J.; Bock, W.J.; Weber, F. 2001: MR imaging and single-photon emission CT findings after gene therapy for human glioblastoma. Ajnr. American Journal of Neuroradiology 22(8): 1517-1527
Ogasawara, T.; Kitagawa, Y.; Ogawa, T.; Yamada, T.; Kawamura, Y.; Sano, K. 2001: MR imaging and thermography of facial angioedema: a case report. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 92(4): 473-476
Levine, D.; Trop, I.; Mehta, T.S.; Barnes, P.D. 2002: MR imaging appearance of fetal cerebral ventricular morphology. Radiology 223(3): 652-660
Turetschek, K.; Huber, S.; Floyd, E.; Helbich, T.; Roberts, T.P.; Shames, D.M.; Tarlo, K.S.; Wendland, M.F.; Brasch, R.C. 2001: MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 218(2): 562-569
Bradley, W.G.; Shey, R.B. 2000: MR imaging evaluation of seizures. Radiology 214(3): 651-656
Lee, W.; Chang, K.H.; Choe, G.; Chi, J.G.; Chung, C.K.; Kim, I.H.; Han, M.H.; Park, S.W.; Shin, S.J.; Koh, Y.H. 2000: MR imaging features of clear-cell meningioma with diffuse leptomeningeal seeding. Ajnr. American Journal of Neuroradiology 21(1): 130-132
Kent, M.; Delahunta, A.; Tidwell, A.S. 2001: MR imaging findings in a dog with intravascular lymphoma in the brain. Veterinary Radiology and Ultrasound 42(6): 504-510
Caro, P.A.; Scavina, M.; Hoffman, E.; Pegoraro, E.; Marks, H.G. 1999: MR imaging findings in children with merosin-deficient congenital muscular dystrophy. Ajnr. American Journal of Neuroradiology 20(2): 324-326
Byun, W.M.; Kim, O.L.; Kim, D. 2000: MR imaging findings of Rathke's cleft cysts: significance of intracystic nodules. Ajnr. American Journal of Neuroradiology 21(3): 485-488
Zimmerman, R.D. 1999: MR imaging findings of enteroviral encephalomyelitis: an outbreak in Taiwan. Ajnr. American Journal of Neuroradiology 20(10): 1775-1776
Roychowdhury, S.; Loevner, L.A.; Yousem, D.M.; Chalian, A.; Montone, K.T. 2000: MR imaging for predicting neoplastic invasion of the cervical esophagus. Ajnr. American Journal of Neuroradiology 21(9): 1681-1687
Urban, M.; Rosen, H.R.; Hölbling, N.; Feil, W.; Hochwarther, G.; Hruby, W.; Schiessel, R. 2000: MR imaging for the preoperative planning of sphincter-saving surgery for tumors of the lower third of the rectum: use of intravenous and endorectal contrast materials. Radiology 214(2): 503-508
Wittsack, H-Jörg.; Ritzl, A.; Fink, G.R.; Wenserski, F.; Siebler, M.; Seitz, Rüdiger.J.; Mödder, U.; Freund, H-Joachim. 2002: MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology 222(2): 397-403
Wijdicks, E.F.; Campeau, N.G.; Miller, G.M. 2001: MR imaging in comatose survivors of cardiac resuscitation. Ajnr. American Journal of Neuroradiology 22(8): 1561-1565
Togashi, K. 2002: MR imaging in obstetrics and gynecology. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 62(1): 7-16
Orel, S.G.; Dougherty, C.S.; Reynolds, C.; Czerniecki, B.J.; Siegelman, E.S.; Schnall, M.D. 2000: MR imaging in patients with nipple discharge: initial experience. Radiology 216(1): 248-254
Tukeva, T.A.; Aronen, H.J.; Karjalainen, P.T.; Molander, P.; Paavonen, T.; Paavonen, J. 1999: MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology 210(1): 209-216
Wijdicks, E.F.; Schievink, W.I.; Miller, G.M. 1998: MR imaging in pretruncal nonaneurysmal subarachnoid hemorrhage: is it worthwhile?. Stroke 29(12): 2514-2516
Zhang, Y.nting; Cui, Jianling; Liu, Xuwen; Pu, Peiyu; Wang, Guangxiu; Wu, Enhui 1998: MR imaging in rat glioma model and gene therapy using EGFR antisense RNA. Chinese Medical Journal (English Edition) 111(11): 993-997
Kohno, A.; Yunoki, M.; Yanagida, T. 1999: MR imaging in the diagnosis of ectopic pregnancy. Dokkyo Journal of Medical Sciences 26(3): 415-417
Fischbein, N.J.; Kaplan, M.J.; Jackler, R.K.; Dillon, W.P. 2001: MR imaging in two cases of subacute denervation change in the muscles of facial expression. Ajnr. American Journal of Neuroradiology 22(5): 880-884
Genovese, E.; Maghnie, M.; Maggiore, G.; Tinelli, C.; Lizzoli, F.; De Giacomo, C.; Pozza, S.; Campani, R. 2000: MR imaging of CNS involvement in children affected by chronic liver disease. Ajnr. American Journal of Neuroradiology 21(5): 845-851
Maki, D.D.; Yousem, D.M.; Corcoran, C.; Galetta, S.L. 1999: MR imaging of Dejerine-Sottas disease. Ajnr. American Journal of Neuroradiology 20(3): 378-380
Mahallati, H.; Wallace, C.J.; Hunter, K.M.; Bilbao, J.M.; Clark, A.W. 1999: MR imaging of a hemorrhagic and granulomatous cyst of the ligamentum flavum with pathologic correlation. Ajnr. American Journal of Neuroradiology 20(6): 1166-1168
Silberstein, M. 2000: MR imaging of acute cervical spine injuries. Radiology 217(1): 301-303
Kim, A.Y.; Han, J.K.; Kim, T.K.; Park, S.J.; Choi, B.I. 2000: MR imaging of advanced gastric cancer: Comparison of various MR pulse sequences using water and gadopentetate dimeglumine as oral contrast agents. Abdominal Imaging 25(1): 7-13
Mahboubi, S.; Gheyi, V. 2001: MR imaging of airway obstruction in infants and children. International Journal of Pediatric Otorhinolaryngology 57(3): 219-227
Bluemke, D.A.; Krupinski, E.A.; Ovitt, T.; Gear, K.; Unger, E.; Axel, L.; Boxt, L.M.; Casolo, G.; Ferrari, V.A.; Funaki, B.; Globits, S.; Higgins, C.B.; Julsrud, P.; Lipton, M.; Mawson, J.; Nygren, A.; Pennell, D.J.; Stillman, A.; White, R.D.; Wichter, T.; Marcus, F. 2003: MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology 99(3): 153-162
Hargreaves, B.A.; Gold, G.E.; Lang, P.K.; Conolly, S.M.; Pauly, J.M.; Bergman, G.; Vandevenne, J.; Nishimura, D.G. 1999: MR imaging of articular cartilage using driven equilibrium. Magnetic Resonance in Medicine 42(4): 695-703
Krinsky, G.A.; Lee, V.S. 2000: MR imaging of cirrhotic nodules. Abdominal Imaging 25(5): 471-482
Wilms, G. 2001: MR imaging of colloid cysts of the third ventricle. AJNR. American Journal of Neuroradiology 22(8): 1632
Saam, B.T.; Yablonskiy, D.A.; Kodibagkar, V.D.; Leawoods, J.C.; Gierada, D.S.; Cooper, J.D.; Lefrak, S.S.; Conradi, M.S. 2000: MR imaging of diffusion of (3)He gas in healthy and diseased lungs. Magnetic Resonance in Medicine 44(2): 174-179
Gabata, T.; Kadoya, M.; Mori, A.; Kobayashi, S.; Sanada, J.; Matsui, O. 2000: MR imaging of focal splenic extramedullary hematopoiesis in polycythemia vera: Case report. Abdominal Imaging 25(5): 514-516
Asanuma, T.; Hirano, Y.; Yamamoto, K.; Kon, Y.; Shimokawa, S.; Kuwabara, M. 1999: MR imaging of hepatic injury in the LEC rat under a high magnetic field (7.05 T). Journal of Veterinary Medical Science 61(3): 239-244
Gelman, N.; Gorell, J.M.; Barker, P.B.; Savage, R.M.; Spickler, E.M.; Windham, J.P.; Knight, R.A. 1999: MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 210(3): 759-767
Medina, L.S. 2000: MR imaging of hypertrophic olivary degeneration: is there a role for metaanalysis?. AJNR. American Journal of Neuroradiology 21(6): 998-999
Suzuki, H.; Takanashi, J.; Kobayashi, K.; Nagasawa, K.; Tashima, K.; Kohno, Y. 2001: MR imaging of idiopathic intracranial hypertension. Ajnr. American Journal of Neuroradiology 22(1): 196-199
Davis, L.M.; Spencer, D.D.; Spencer, S.S.; Bronen, R.A. 1999: MR imaging of implanted depth and subdural electrodes: Is it safe?. Epilepsy Research 35(2): 95-98
Hashmi, R.; Uetani, M.; Hayashi, K.; Aso, N.; Kawahara, Y.; Nakahara, N. 1999: MR imaging of intra-articular / juxta-articular mass lesions. Acta Medica Nagasakiensia 44(3-4): 7-19
Karantanas, A.H. 2001: MR imaging of intracranial epidermoid tumors: Specific diagnosis with Turbo-FLAIR pulse sequence. Computerized Medical Imaging and Graphics: the Official Journal of the Computerized Medical Imaging Society 25(3): 249-255
Hauger, O.; Delalande, C.; Trillaud, H.; Deminiere, C.; Quesson, B.; Kahn, H.; Cambar, J.; Combe, C.; Grenier, N. 1999: MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome. Magnetic Resonance in Medicine 41(1): 156-162
Williams, R.L.; Beatty, R.L.; Kanal, E.; Weissman, J.L. 1999: MR imaging of intraventricular silicone: case report. Radiology 212(1): 151-154
Ma, L.; Yu, S.; Cai, Y.; Liang, L.; Guo, X. 2003: MR imaging of meningeal carcinomatosis by systemic malignancy. Chinese Medical Sciences Journal 18(1): 36-40
Jensen, J.H.; Chandra, R. 2000: MR imaging of microvasculature. Magnetic Resonance in Medicine 44(2): 224-230
Fichtlscherer, B.; Mülsch, A. 2000: MR imaging of nitrosyl-iron complexes: experimental study in rats. Radiology 216(1): 225-231
Demirpolat, G.; Sener, R.N.; Stun, E.E. 1999: MR imaging of pachydermoperiostosis. Journal of Neuroradiology 26(1): 61-63
Diehl, S.J.; Lehmann, K.J.; Gaa, J.; McGill, S.; Hoffmann, V.; Georgi, M. 1999: MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate. Investigative Radiology 34(9): 589-595
Burton, B.S.; Syms, M.J.; Petermann, G.W.; Burgess, L.P. 2000: MR imaging of patients with carotidynia. Ajnr. American Journal of Neuroradiology 21(4): 766-769
Takahashi, N.; Niitsu, M.; Itai, Y.; Sato, M.; Kujiraoka, Y.; Ikeda, K.; Kanamori, A. 2001: MR imaging of posterior cruciate ligament injuries. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 61(8): 421-426
Yabuki, T.; Togami, I.; Kitagawa, T.; Sasai, N.; Tsushima, T.; Shirasaki, Y.; Hiraki, Y. 2003: MR imaging of renal cell carcinoma: associations among signal intensity, tumor enhancement, and pathologic findings. Acta Medica Okayama 57(4): 179-186
Sari, A.; Ozyavuz, R.; Demirci, A.; Ercin, C.; Arslan, A.; Yuzuncu, A.K.; Gumele, H.R. 1999: MR imaging of renal vein occlusion in dogs. Investigative Radiology 34(8): 523-529
Bekiesińska-Figatowska, M.; Bulski, T.; Rózyczka, I.; Furmanek, M.; Walecki, J. 2001: MR imaging of seven presumed cases of central pontine and extrapontine myelinolysis. Acta Neurobiologiae Experimentalis 61(2): 141-144
Wu, T.; Felmlee, J.P.; Greenleaf, J.F.; Riederer, S.J.; Ehman, R.L. 2000: MR imaging of shear waves generated by focused ultrasound. Magnetic Resonance in Medicine 43(1): 111-115
Minowa, O.; Ozaki, Y.; Sumi, Y. 2002: MR imaging of small bowel with water administration. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 62(2): 73-78
Krombach, G.A.; Wendland, M.F.; Higgins, C.B.; Saeed, M. 2002: MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: value of blood pool ultrasmall superparamagnetic particles of iron oxide. Radiology 225(2): 479-486
Tateishi, U.; Terae, S.; Ogata, A.; Sawamura, Y.; Suzuki, Y.; Abe, S.; Miyasaka, K. 2001: MR imaging of the brain in lymphomatoid granulomatosis. Ajnr. American Journal of Neuroradiology 22(7): 1283-1290
Kozić, D.; Svetel, M.; Petrović, B.; Dragasević, N.; Semnic, R.; Kostić, V.S. 2003: MR imaging of the brain in patients with hepatic form of Wilson's disease. European Journal of Neurology 10(5): 587-592
Quencer, R.M.; Bradley, W.G. 2001: MR imaging of the brain: what constitutes the minimum acceptable capability?. AJNR. American Journal of Neuroradiology 22(8): 1449-1450
Cellerini, M.; Salti, S.; Desideri, V.; Marconi, G. 2000: MR imaging of the cauda equina in hereditary motor sensory neuropathies: correlations with sural nerve biopsy. Ajnr. American Journal of Neuroradiology 21(10): 1793-1798
Naganawa, S.; Ito, T.; Iwayama, E.; Fukatsu, H.; Ishigaki, T.; Nakashima, T.; Ichinose, N. 1999: MR imaging of the cochlear modiolus: area measurement in healthy subjects and in patients with a large endolymphatic duct and sac. Radiology 213(3): 819-823
Dubovsky, E.C.; Booth, T.N.; Vezina, G.; Samango-Sprouse, C.A.; Palmer, K.M.; Brasseux, C.O. 2001: MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1. Ajnr. American Journal of Neuroradiology 22(1): 190-195
Naganawa, S.; Koshikawa, T.; Iwayama, E.; Fukatsu, H.; Ishiguchi, T.; Ishigaki, T.; Ikeda, M.; Nakashima, T.; Ichinose, N. 2000: MR imaging of the enlarged endolymphatic duct and sac syndrome by use of a 3D fast asymmetric spin-echo sequence: volume and signal-intensity measurement of the endolymphatic duct and sac and area measurement of the cochlear modiolus. Ajnr. American Journal of Neuroradiology 21(9): 1664-1669
Boku, H.; Takehara, Y.; Isoda, H.; Isogai, S.; Kaneko, M. 1999: MR imaging of the gastrointestinal tract with half-Fourier single-shot fast spin echo (SSFSE). Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 59(5): 176-182
Cottin, Y.; Touzery, C.; Guy, F.; Lalande, A.; Ressencourt, O.; Roy, S.; Walker, P.M.; Louis, P.; Brunotte, F.; Wolf, J.E. 1999: MR imaging of the heart in patients after myocardial infarction: effect of increasing intersection gap on measurements of left ventricular volume, ejection fraction, and wall thickness. Radiology 213(2): 513-520
Miller, S.; Simonetti, O.P.; Carr, J.; Kramer, U.; Finn, J.Paul. 2002: MR Imaging of the heart with cine true fast imaging with steady-state precession: influence of spatial and temporal resolutions on left ventricular functional parameters. Radiology 223(1): 263-269
Savolainen, S.; Laakso, M.P.; Paljärvi, L.; Alafuzoff, I.; Hurskainen, H.; Partanen, K.; Soininen, H.; Vapalahti, M. 2000: MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysis. Ajnr. American Journal of Neuroradiology 21(2): 409-414
Georgiades, C.S.; Itoh, R.; Golay, X.; van Zijl, P.C.; Melhem, E.R. 2001: MR imaging of the human brain at 1.5 T: regional variations in transverse relaxation rates in the cerebral cortex. Ajnr. American Journal of Neuroradiology 22(9): 1732-1737
Weishaupt, D.; Zanetti, M.; Hodler, J.; Boos, N. 1998: MR imaging of the lumbar spine: prevalence of intervertebral disk extrusion and sequestration, nerve root compression, end plate abnormalities, and osteoarthritis of the facet joints in asymptomatic volunteers. Radiology 209(3): 661-666
Wild, J.M.; Schmiedeskamp, J.; Paley, M.N.J.; Filbir, F.; Fichele, S.; Kasuboski, L.; Knitz, F.; Woodhouse, N.; Swift, A.; Heil, W.; Mill, G.H.; Wolf, M.; Griffiths, P.D.; Otten, E.; van Beek, E.J.R. 2002: MR imaging of the lungs with hyperpolarized helium-3 gas transported by air. Physics in Medicine and Biology 47(13): N185-N190
Theumann, N.H.; Pfirrmann, C.W.A.; Drapé, J-Luc.; Trudell, D.J.; Resnick, D. 2002: MR imaging of the metacarpophalangeal joints of the fingers: part I. Conventional MR imaging and MR arthrographic findings in cadavers. Radiology 222(2): 437-445
Pfirrmann, C.W.A.; Theumann, N.H.; Botte, M.J.; Drapé, J-Luc.; Trudell, D.J.; Resnick, D. 2002: MR imaging of the metacarpophalangeal joints of the fingers: part II. Detection of simulated injuries in cadavers. Radiology 222(2): 447-452
Chong, J.; Chan, L.L.; Langstein, H.N.; Ginsberg, L.E. 2001: MR imaging of the muscular component of myocutaneous flaps in the head and neck. Ajnr. American Journal of Neuroradiology 22(1): 170-174
Sherman, P.M.; Sanders, T.G.; Morrison, W.B.; Schweitzer, M.E.; Leis, H.T.; Nusser, C.A. 2001: MR imaging of the posterior cruciate ligament graft: initial experience in 15 patients with clinical correlation. Radiology 221(1): 191-198
Endo, H.; Niitsu, M.; Wada, M.; Yoshizako, T.; Itai, Y. 1999: MR imaging of the posterolateral aspect of the knee. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 59(13): 750-753
Hobby, J.L.; Dixon, A.K.; Bearcroft, P.W.; Tom, B.D.; Lomas, D.J.; Rushton, N.; Matthewson, M.H. 2001: MR imaging of the wrist: effect on clinical diagnosis and patient care. Radiology 220(3): 589-593
Baron, Y.; Barkovich, A.J. 1999: MR imaging of tuberous sclerosis in neonates and young infants. AJNR. American Journal of Neuroradiology 20(5): 907-916
Catalaa, I.; Fulton, J.C.; Zhang, X.; Udupa, J.K.; Kolson, D.; Grossman, M.; Wei, L.; McGowan, J.C.; Polansky, M.; Grossman, R.I. 1999: MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing. Ajnr. American Journal of Neuroradiology 20(9): 1613-1618
Peterson, A.M.; Meltzer, C.C.; Evanson, E.J.; Flickinger, J.C.; Kondziolka, D. 1999: MR imaging response of brain metastases after gamma knife stereotactic radiosurgery. Radiology 211(3): 807-814
Akhaddar, A.; El-Hassani, M.Y.R.; Gazzaz-Rifi, M.; Chakir, N.; El-Khamlichi, A.; Jiddane, M. 2000: MR imaging study in intradural extramedullary tuberculoma. Case report and literature review. Journal of Neuroradiology 27(2): 107-111
Matsushita, M.; Kurata, H.; Kase, H.; Arakawa, M.; Aoki, Y.; Tanaka, K. 2001: MR imaging underestimates stromal invasion in patients with adenocarcinoma of the uterine cervix. European Journal of Gynaecological Oncology 22(3): 201-203
Kaim, A.H.; Wischer, T.; O'Reilly, T.; Jundt, G.; Fröhlich, J.; von Schulthess, G.K.; Allegrini, P.R. 2002: MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats. Radiology 225(3): 808-814
Hofman, P.A.; Stapert, S.Z.; van Kroonenburgh, M.J.; Jolles, J.; de Kruijk, J.; Wilmink, J.T. 2001: MR imaging, single-photon emission CT, and neurocognitive performance after mild traumatic brain injury. Ajnr. American Journal of Neuroradiology 22(3): 441-449
Bendszus, M.; Martin-Schrader, I.; Warmuth-Metz, M.; Hofmann, E.; Solymosi, L. 2000: MR imaging- and MR spectroscopy-revealed changes in meningiomas for which embolization was performed without subsequent surgery. Ajnr. American Journal of Neuroradiology 21(4): 666-669
Hynynen, K.; Pomeroy, O.; Smith, D.N.; Huber, P.E.; McDannold, N.J.; Kettenbach, J.; Baum, J.; Singer, S.; Jolesz, F.A. 2001: MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 219(1): 176-185
Silverman, S.G.; Tuncali, K.; Adams, D.F.; vanSonnenberg, E.; Zou, K.H.; Kacher, D.F.; Morrison, P.R.; Jolesz, F.A. 2000: MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 217(3): 657-664
Merkle, E.M.; Haaga, J.R.; Duerk, J.L.; Jacobs, G.H.; Brambs, H.J.; Lewin, J.S. 1999: MR imaging-guided radio-frequency thermal ablation in the pancreas in a porcine model with a modified clinical C-arm system. Radiology 213(2): 461-467
Nour, S.Gamal.; Aschoff, A.J.; Mitchell, I.C.S.; Emancipator, S.N.; Duerk, J.L.; Lewin, J.S. 2002: MR imaging-guided radio-frequency thermal ablation of the lumbar vertebrae in porcine models. Radiology 224(2): 452-462
Manke, C.; Nitz, W.R.; Djavidani, B.; Strotzer, M.; Lenhart, M.; Völk, M.; Feuerbach, S.; Link, J. 2001: MR imaging-guided stent placement in iliac arterial stenoses: a feasibility study. Radiology 219(2): 527-534
Fulton, J.C.; Grossman, R.I.; Udupa, J.; Mannon, L.J.; Grossman, M.; Wei, L.; Polansky, M.; Kolson, D.L. 1999: MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis. Ajnr. American Journal of Neuroradiology 20(10): 1951-1955
Robertson, R.L.; Maier, S.E.; Robson, C.D.; Mulkern, R.V.; Karas, P.M.; Barnes, P.D. 1999: MR line scan diffusion imaging of the brain in children. Ajnr. American Journal of Neuroradiology 20(3): 419-425
Robertson, R.L.; Maier, S.E.; Mulkern, R.V.; Vajapayam, S.; Robson, C.D.; Barnes, P.D. 2000: MR line-scan diffusion imaging of the spinal cord in children. Ajnr. American Journal of Neuroradiology 21(7): 1344-1348
Robertson, R.L.; Ben-Sira, L.; Barnes, P.D.; Mulkern, R.V.; Robson, C.D.; Maier, S.E.; Rivkin, M.J.; du Plessis, A. 1999: MR line-scan diffusion-weighted imaging of term neonates with perinatal brain ischemia. Ajnr. American Journal of Neuroradiology 20(9): 1658-1670
Van Goethem, M.; Schelfout, K.; Jacobs, W.; Verslegers, I.; Biltjes, I.; De Raeve, H.; De Schepper, A. 2003: MR mammography of a primary squamous cell carcinoma of the breast: A case report. Breast 12(3): 212-214
Foley, J.M.; Jayaraman, R.C.; Prior, B.M.; Pivarnik, J.M.; Meyer, R.A. 1999: MR measurements of muscle damage and adaptation after eccentric exercise. Journal of Applied Physiology 87(6): 2311-2318
Quast, M.J.; Neumeister, H.; Ezell, E.L.; Budelmann, B.U. 2001: MR microscopy of cobalt-labeled nerve cells and pathways in an invertebrate brain (Sepia officinalis, Cephalopoda). Magnetic Resonance in Medicine 45(4): 575-579
Chen, X.J.; Chawla, M.S.; Hedlund, L.W.; Möller, H.E.; MacFall, J.R.; Johnson, G.A. 1998: MR microscopy of lung airways with hyperpolarized 3He. Magnetic Resonance in Medicine 39(1): 79-84
Bulte, J.W.M.; Ben-Hur, T.; Miller, B.R.; Mizrachi-Kol, R.; Einstein, O.; Reinhartz, E.; Zywicke, H.A.; Douglas, T.; Frank, J.A. 2003: MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain. Magnetic Resonance in Medicine 50(1): 201-205
Grant, S.C.; Buckley, D.L.; Gibbs, S.; Webb, A.G.; Blackband, S.J. 2001: MR microscopy of multicomponent diffusion in single neurons. Magnetic Resonance in Medicine 46(6): 1107-1112
Ahrens, E.T.; Laidlaw, D.H.; Readhead, C.; Brosnan, C.F.; Fraser, S.E.; Jacobs, R.E. 1998: MR microscopy of transgenic mice that spontaneously acquire experimental allergic encephalomyelitis. Magnetic Resonance in Medicine 40(1): 119-132
Artemov, D.; Mori, N.; Okollie, B.; Bhujwalla, Z.M. 2003: MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magnetic Resonance in Medicine 49(3): 403-408
Pfirrmann, C.W.; Binkert, C.A.; Zanetti, M.; Boos, N.; Hodler, J. 2001: MR morphology of alar ligaments and occipitoatlantoaxial joints: study in 50 asymptomatic subjects. Radiology 218(1): 133-137
Jarvik, J.G.; Yuen, E.; Haynor, D.R.; Bradley, C.M.; Fulton-Kehoe, D.; Smith-Weller, T.; Wu, R.; Kliot, M.; Kraft, G.; Wang, L.; Erlich, V.; Heagerty, P.J.; Franklin, G.M. 2002: MR nerve imaging in a prospective cohort of patients with suspected carpal tunnel syndrome. Neurology 58(11): 1597-1602
Christoforidis, G.A.; Spickler, E.M.; Recio, M.V.; Mehta, B.M. 1999: MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. Ajnr. American Journal of Neuroradiology 20(4): 655-669
Van-Waesberghe, J.-Hein, T.M.; Van-Buchem, M., A.; Filippi, M.; Castelijns, J., A.; Rocca, M., A.; Van-Der-Boom, R.; Polman, C., H.; Barkhof, F. 1998: MR outcome parameters in multiple sclerosis: Comparison of surface-based thresholding segmentation and magnetization transfer ratio histographic analysis in relation to disability (a preliminary note). AJNR 19(10): 1857-1862
Calamante, F.; Ganesan, V.; Kirkham, F.J.; Jan, W.; Chong, W.K.; Gadian, D.G.; Connelly, A. 2001: MR perfusion imaging in Moyamoya Syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke 32(12): 2810-2816
Hillis, A.E.; Barker, P.B.; Beauchamp, N.J.; Gordon, B.; Wityk, R.J. 2000: MR perfusion imaging reveals regions of hypoperfusion associated with aphasia and neglect. Neurology 55(6): 782-788
Callot, V.; Canet, E.; Brochot, J.; Viallon, M.; Humblot, H.; Briguet, A.; Tournier, H.; Crémillieux, Y. 2001: MR perfusion imaging using encapsulated laser-polarized 3He. Magnetic Resonance in Medicine 46(3): 535-540
Hoogeveen, R.M.; Bakker, C.J.; Viergever, M.A. 1999: MR phase-contrast flow measurement with limited spatial resolution in small vessels: Value of model-based image analysis. Magnetic Resonance in Medicine 41(3): 520-528
Stanisz, G.J.; Midha, R.; Munro, C.A.; Henkelman, R.M. 2001: MR properties of rat sciatic nerve following trauma. Magnetic Resonance in Medicine 45(3): 415-420
Blandino, A.; Minutoli, F.; Gaeta, M.; Settineri, N.; Pandolfo, I. 2003: MR pyelography in the assessment of hydroureteronephrosis: single-shot thick-slab RARE versus multislice HASTE sequences. Abdominal Imaging 28(3): 433-439
Agildere, A.M.; Tarhan, N.C.; Ergeneli, M.H.; Yologlu, Z.; Kurt, A.; Akgun, S.; Kayahan, E.M. 2003: MR rectography evaluation of rectoceles with oral gadopentetate dimeglumine and polyethylene glycol solution. Abdominal Imaging 28(1): 28-35
Lee, V.S.; Rusinek, H.; Johnson, G.; Rofsky, N.M.; Krinsky, G.A.; Weinreb, J.C. 2001: MR renography with low-dose gadopentetate dimeglumine: feasibility. Radiology 221(2): 371-379
Kim, D.M.; Xanthakos, S.A.; Tupler, L.A.; Barboriak, D.P.; Charles, H.Cecil.; MacFall, J.R.; Krishnan, K.Ranga.Rama. 2002: MR signal intensity of gray matter/white matter contrast and intracranial fat: Effects of age and sex. Psychiatry Research 114(3): 149-161
Hasumi, M.; Suzuki, K.; Oya, N.; Ito, K.; Kurokawa, K.; Fukabori, Y.; Yamanaka, H. 2002: MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer. Anticancer Research 22(2b): 1205-1208
Colla, M.; Ende, G.; Bohrer, M.; Deuschle, M.; Kronenberg, G.; Henn, F.; Heuser, I. 2003: MR spectroscopy in Alzheimer's disease: Gender differences in probabilistic learning capacity. Neurobiology of Aging 24(4): 545-552
Bendszus, M.; Warmuth-Metz, M.; Klein, R.; Burger, R.; Schichor, C.; Tonn, J.C.; Solymosi, L. 2000: MR spectroscopy in gliomatosis cerebri. Ajnr. American Journal of Neuroradiology 21(2): 375-380
Estève, F.; Grand, S.; Rubin, C.; Hoffmann, D.; Pasquier, B.; Graveron-Demilly, D.; Mahdjoub, R.; Le Bas, J.F. 1999: MR spectroscopy of bilateral thalamic gliomas. Ajnr. American Journal of Neuroradiology 20(5): 876-881
Savic, I.; Lekvall, A.; Greitz, D.; Helms, G. 2000: MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy. Epilepsia 41(3): 290-296
Graham, G.D.; Barker, P.B.; Brooks, W.M.; Morris, D.C.; Ahmed, W.; Bryniarski, E.; Hearshen, D.O.; Sanders, J.A.; Holshouser, B.A.; Turkel, C.C. 2000: MR spectroscopy study of dichloroacetate treatment after ischemic stroke. Neurology 55(9): 1376-1378
King, S.B.; Ryner, L.N.; Tomanek, B.; Sharp, J.C.; Smith, I.C. 1999: MR spectroscopy using multi-ring surface coils. Magnetic Resonance in Medicine 42(4): 655-664
Stefan, H.; Pauli, E.; Eberhardt, K.E.; Schäfer, I.; Hopp, P.; Huk, W.J. 2000: MRI spectroscopy, T2 relaxometry, and postoperative prognosis in cryptogenic temporal lobe epilepsy. Der Nervenarzt 71(4): 282-287
Ito, Y.; Berkowitz, B.A. 2001: MR studies of retinal oxygenation. Vision Research 41(10-11): 1307-1311
Epstein, F.H.; Yang, Z.; Gilson, W.D.; Berr, S.S.; Kramer, C.M.; French, B.A. 2002: MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions. Magnetic Resonance in Medicine 48(2): 399-403
Germain, D.; Vahala, E.; Ehnholm, G.J.; Vaara, T.; Ylihautala, M.; Savart, M.; Laurent, A.; Tanttu, J.; Saint-Jalmes, H. 2002: MR temperature measurement in liver tissue at 0.23 T with a steady-state free precession sequence. Magnetic Resonance in Medicine 47(5): 940-947
Dohi, M.; Miida, K.; Harada, J.; Komura, K.; Takahashi, T. 1999: MR temperature monitoring by the proton phase shift (PPS) method with a 0.3T open-type MR scanner: experimental study. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 59(13): 788-790
Louca, G.; Liberopoulos, K.; Fidas, A.; Nikolakopoulou, Z.; Lykourinas, M.; Strigaris, K. 1999: MR urography in the diagnosis of urinary tract obstruction. European Urology 35(2): 102-108
Nolte-Ernsting, C.C.A.; Staatz, G.; Tacke, J.; Günther, R.W. 2003: MR urography today. Abdominal Imaging 28(2): 191-209
Rollins, N.; Booth, T.; Shapiro, K. 2000: MR venography in children with complex craniosynostosis. Pediatric Neurosurgery 32(6): 308-315
Tan, I.L.; van Schijndel, R.A.; Pouwels, P.J.; van Walderveen, M.A.; Reichenbach, J.R.; Manoliu, R.A.; Barkhof, F. 2000: MR venography of multiple sclerosis. Ajnr. American Journal of Neuroradiology 21(6): 1039-1042
Hagspiel, K.D.; Altes, T.A.; Mugler, J.P.; Spellman, M.J.; Mata, J.F.; Tustison, N.J.; Brookeman, J.R. 2000: MR virtual colonography using hyperpolarized (3)He as an endoluminal contrast agent: demonstration of feasibility. Magnetic Resonance in Medicine 44(5): 813-816
Neri, E.; Boraschi, P.; Braccini, G.; Caramella, D.; Perri, G.; Bartolozzi, C. 1999: MR virtual endoscopy of the pancreaticobiliary tract. Magnetic Resonance Imaging 17(1): 59-67
Agartz, I.; Brag, S.; Franck, J.; Hammarberg, A.; Okugawa, G.; Svinhufvud, K.; Bergman, H. 2003: MR volumetry during acute alcohol withdrawal and abstinence: a descriptive study. Alcohol and Alcoholism 38(1): 71-78
Jutila, L.; Ylinen, A.; Partanen, K.; Alafuzoff, I.; Mervaala, E.; Partanen, J.; Vapalahti, M.; Vainio, P.; Pitkänen, A. 2001: MR volumetry of the entorhinal, perirhinal, and temporopolar cortices in drug-refractory temporal lobe epilepsy. AJNR. American Journal of Neuroradiology 22(8): 1490-1501
Nemzek, W.R.; Brodie, H.A.; Hecht, S.T.; Chong, B.W.; Babcook, C.J.; Seibert, J.A. 2000: MR, CT, and plain film imaging of the developing skull base in fetal specimens. Ajnr. American Journal of Neuroradiology 21(9): 1699-1706
Voigtlaender, T.; Kreitner, K.F.; Wittlinger, T.; Petersen, S.; Horstick, G.; Kalden, P.; Meyer, J. 2001: MR-Angiographie und Flussmessung in Koronararterien und koronaren Bypassgefaessen. Zeitschrift fuer Kardiologie 90(12): 929-938
Kimmig, H.; Greenlee, M.W.; Huethe, F.; Mergner, T. 1999: MR-Eyetracker: A new method for eye movement recording in functional magnetic resonance imaging. Experimental Brain Research 126(3): 443-449
Steiner, P.; Hany, T.H.; Mckinnon, G.; Follath, F.; Debatin, J.F. 2000: MR-angiography in the diagnosis of pulmonary embolism. Intensivmedizin und Notfallmedizin 37(Suppl 1): 63-70
Eisenhart-Rothe, R.V.; Wiedemann, E.; Bonel, H.; Eckstein, F.; Reiser, M.; Englmeier, K.H.; Graichen, H. 2000: MR-basierte 3D-Analyse der glenohumeralen Translation bei Patienten mit Schulterinstabilitaet. Zeitschrift fuer Orthopaedie und ihre Grenzgebiete 138(6): 481-486
Vahldiek, G.; Broemel, T.; Klapdor, R. 1999: MR-cholangiopancreaticography (MRCP) and MR-angiography: morphologic changes with magnetic resonance imaging. Anticancer Research 19(4a): 2451-2458
Pathak, A.P.; Schmainda, K.M.; Ward, B.D.; Linderman, J.R.; Rebro, K.J.; Greene, A.S. 2001: MR-derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis. Magnetic Resonance in Medicine 46(4): 735-747
Kendell, K.R.; Wu, T.; Felmlee, J.P.; Lewis, B.D.; Ehman, R.L. 1998: MR-guided focused-ultrasound ablation system: determination of precision and accuracy in preparation for clinical trials. Radiology 209(3): 856-861
Tacke, J.; Adam, G.; Speetzen, R.; Brucksch, K.; Bücker, A.; Heshel, I.; Prescher, A.; van Vaals, J.J.; Hunter, D.W.; Rau, G.; Günther, R.W. 1998: MR-guided interstitial cryotherapy of the liver with a novel, nitrogen-cooled cryoprobe. Magnetic Resonance in Medicine 39(3): 354-360
Vogl, T.J.; Mack, M.G.; Straub, R.; Mueller, P.; Eichler, K.; Engelmann, K.; Felix, R. 1998: MR-guided laser-induced thermotherapy of malignant liver lesions: Technique and results. Onkologie 21(5): 412-419
Baur, A.; Stäbler, A.; Wendtner, C.M.; Arbogast, S.; Rahman, S.A.; Santl, M.; Issels, R.; Reiser, M. 2003: MR-imaging changes of musculoskeletal soft-tissue sarcomas associated with neoadjuvant chemotherapy and hyperthermia. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 19(4): 391-401
Alperin, N.J.; Lee, S.H.; Loth, F.; Raksin, P.B.; Lichtor, T. 2000: MR-Intracranial pressure (ICP): a method to measure intracranial elastance and pressure noninvasively by means of MR imaging: baboon and human study. Radiology 217(3): 877-885
Gründer, W.; Wagner, M.; Werner, A. 1998: MR-microscopic visualization of anisotropic internal cartilage structures using the magic angle technique. Magnetic Resonance in Medicine 39(3): 376-382
Takanashi, J.; Sugita, K.; Tanabe, Y.; Nagasawa, K.; Inoue, K.; Osaka, H.; Kohno, Y. 1999: MR-revealed myelination in the cerebral corticospinal tract as a marker for Pelizaeus-Merzbacher's disease with proteolipid protein gene duplication. Ajnr. American Journal of Neuroradiology 20(10): 1822-1828
Pirzkall, A.; Mcknight, T.R.; Graves, E.E.; Carol, M.P.; Sneed, P.K.; Wara, W.W.; Nelson, S.J.; Verhey, L.J.; Larson, D.A. 2001: MR-spectroscopy guided target delineation for high-grade gliomas. International Journal of Radiation Oncology Biology Physics 50(4): 915-928
Bos, C.; Smits, J.H.; Zijlstra, J.J.; van Der Mark, W.A.; Blankestijn, P.J.; Bakker, C.J.; Viergever, M.A.; Mali, W.P. 2001: MRA of hemodialysis access grafts and fistulae using selective contrast injection and flow interruption. Magnetic Resonance in Medicine 45(4): 557-561
Huelsenbeck, J.P.; Ronquist, F. 2001: MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17(8): 754-755
Anonymous 1999: MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal 20(10): 725-741
Collins, R.; Armitage, J.; Parish, S.; Sleigh, P.; Peto, R. 2003: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet 361(9374): 2005-2016
Kimura, T.; Itoh, N.; Takehara, M.; Oguro, I.; Ishizaki, J-ichi.; Nakanishi, T.; Tanaka, K. 2002: MRE-binding transcription factor-1 is activated during endotoxemia: A central role for metallothionein. Toxicology Letters 129(1-2): 77-84
Ataian, Y.; Owens, J.; Hinterberger, T. 2003: MRF4 gene expression in Xenopus embryos and aneural myofibers. Developmental Dynamics: An Official Publication of the American Association of Anatomists 226(3): 551-554
Glenn, D.J.; Maurer, R.A. 1999: MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression. Journal of Biological Chemistry 274(51): 36159-36167
Han, B.; Liu, N.; Yang, X.; Sun, H.B.; Yang, Y.C. 2001: MRG1 expression in fibroblasts is regulated by Sp1/Sp3 and an Ets transcription factor. Journal of Biological Chemistry 276(11): 7937-7942
Leung, J.K.; Berube, N.; Venable, S.; Ahmed, S.; Timchenko, N.; Pereira-Smith, O.M. 2001: MRG15 activates the B-myb promoter through formation of a nuclear complex with the retinoblastoma protein and the novel protein PAM14. Journal of Biological Chemistry 276(42): 39171-39178
Pardo, P.S.; Leung, J.K.; Lucchesi, J.C.; Pereira-Smith, O.M. 2002: MRG15, a novel chromodomain protein, is present in two distinct multiprotein complexes involved in transcriptional activation. Journal of Biological Chemistry 277(52): 50860-50866
Baranger, B.; Cordoliani, Y.S.; Singland, J.D.; Andre, J.L. 1999: MRI - Interest for exploration of non atheromatous arteriopathies of the popliteal fossa. Medecine et Armees 27(1): 31-34
Bakshi, R.; Shaikh, Z.A.; Janardhan, V. 2000: MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 11(1): 15-21
Lansberg, M.G.; O'brien, M.W.; Norbash, A.M.; Moseley, M.E.; Morrell, M.; Albers, G.W. 1999: MRI abnormalities associated with partial status epilepticus. Neurology 52(5): 1021-1027
Rosenbaum, T.; Engelbrecht, V.; Krölls, W.; van Dorsten, F.A.; Hoehn-Berlage, M.; Lenard, H.G. 1999: MRI abnormalities in neurofibromatosis type 1 (NF1): A study of men and mice. Brain and Development 21(4): 268-273
Watkins, K.E.; Vargha-Khadem, F.; Ashburner, J.; Passingham, R.E.; Connelly, A.; Friston, K.J.; Frackowiak, R.S.J.; Mishkin, M.; Gadian, D.G. 2002: MRI analysis of an inherited speech and language disorder: structural brain abnormalities. Brain: a Journal of Neurology 125(Pt 3): 465-478
Henry-Feugeas, M.C.; Azouvi, P.; Fontaine, A.; Denys, P.; Bussel, B.; Maaz, F.; Samson, Y.; Schouman-Claeys, E. 2000: MRI analysis of brain atrophy after severe closed-head injury: Relation to clinical status. Brain Injury 14(7): 597-604
DelBello, M.P.; Strakowski, S.M.; Zimmerman, M.E.; Hawkins, J.M.; Sax, K.W. 1999: MRi analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 21(1): 63-68
Rudin, M.; Baumann, D.; Ekatodramis, D.; Stirnimann, R.; McAllister, K.H.; Sauter, A. 2001: MRI analysis of the changes in apparent water diffusion coefficient, T(2) relaxation time, and cerebral blood flow and volume in the temporal evolution of cerebral infarction following permanent middle cerebral artery occlusion in rats. Experimental Neurology 169(1): 56-63
Mccarley, R.W.; Wible, C.G.; Frumin, M.; Hirayasu, Y.; Levitt, J.J.; Fischer, I.A.; Shenton, M.E. 1999: MRI anatomy of schizophrenia. Biological Psychiatry 45(9): 1099-1119
Saiz, A.; Carreras, E.; Berenguer, J.; Yagüe, J.; Martínez, C.; Marín, P.; Rovira, M.; Pujol, T.; Arbizu, T.; Graus, F. 2001: MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS. Neurology 56(8): 1084-1089
Hierholzer, J.; Luo, L.; Bittner, R.C.; Stroszczynski, C.; Schröder, R.J.; Schoenfeld, N.; Dorow, P.; Loddenkemper, R.; Grassot, A. 2000: MRI and CT in the differential diagnosis of pleural disease. Chest 118(3): 604-609
Patlas, M.; Joseph, A.; Cohen, J.E.; Gomori, J.M. 2003: MRI and MRS of Coffin-Lowry syndrome: a case report. Neurological Research 25(3): 285-286
Gedrange, T.; Winnefeld, K.; Hietschold, V.; Schubert, H.; Harzer, W. 2000: MRI and biochemical investigation of the temporomandibular joint of juvenile pigs after sagittal advancement of the mandibulae. Journal of Experimental Animal Science 41(4): 168-175
Choudhury, R.P.; Fuster, V.; Badimon, J.J.; Fisher, E.A.; Fayad, Z.A. 2002: MRI and characterization of atherosclerotic plaque: Emerging applications and molecular imaging. Arteriosclerosis Thrombosis and Vascular Biology 22(7): 1065-1074
Sener, R.N. 2002: MRI and diffusion MRI in nonparaneoplastic limbic encephalitis. Computerized Medical Imaging and Graphics: the Official Journal of the Computerized Medical Imaging Society 26(5): 339-342
Bartrés-Faz, D.; Junqué, C.; Clemente, I.C.; Serra-Grabulosa, J.M.; Guardia, J.; López-Alomar, A.; Sánchez-Aldeguer, J.; Mercader, J.M.; Bargalló, N.; Olondo, M.; Moral, P. 2001: MRI and genetic correlates of cognitive function in elders with memory impairment. Neurobiology of Aging 22(3): 449-459
Filippi, M.; Rocca, M.A.; Moiola, L.; Martinelli, V.; Ghezzi, A.; Capra, R.; Salvi, F.; Comi, G. 1999: MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology 53(8): 1705-1710
Colombo, B.; Martinelli Boneschi, F.; Rossi, P.; Rovaris, M.; Maderna, L.; Filippi, M.; Comi, G. 2000: MRi and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue. Journal of Neurology 247(7): 506-509
Devine, S.A.; Kirkley, S.M.; Palumbo, C.L.; White, R.F. 2002: MRI and neuropsychological correlates of carbon monoxide exposure: a case report. Environmental Health Perspectives 110(10): 1051-1055
Puri, B.K.; Bydder, G.M.; Counsell, S.J.; Corridan, B.J.; Richardson, A.J.; Hajnal, J.V.; Appel, C.; Mckee, H.M.; Vaddadi, K.S.; Horrobin, D.F. 2002: MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment. Neuroreport 13(1): 123-126
Fatemi, A.; Barker, P.B.; Uluğ, A.M.; Nagae-Poetscher, L.M.; Beauchamp, N.J.; Moser, A.B.; Raymond, G.V.; Moser, H.W.; Naidu, S. 2003: MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy. Neurology 60(8): 1301-1307
Burrel, M.; Llovet, J.M.; Ayuso, C.; Iglesias, C.; Sala, M.; Miquel, R.; Caralt, T.; Ayuso, J.Ramon.; Solé, M.; Sanchez, M.; Brú, Có.; Bruix, J. 2003: MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: An explant correlation. Hepatology 38(4): 1034-1042
Rouvière, O.; Lyonnet, D.; Raudrant, A.; Colin-Pangaud, C.; Chapelon, J.Y.; Bouvier, R.; Dubernard, J.M.; Gelet, A. 2001: MRI appearance of prostate following transrectal HIFU ablation of localized cancer. European Urology 40(3): 265-274
Jack, C.R.; Slomkowski, M.; Gracon, S.; Hoover, T.M.; Felmlee, J.P.; Stewart, K.; Xu, Y.; Shiung, M.; O'Brien, P.C.; Cha, R.; Knopman, D.; Petersen, R.C. 2003: MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 60(2): 253-260
Giedd, J.N.; Rapoport, J.L.; Garvey, M.A.; Perlmutter, S.; Swedo, S.E. 2000: MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. American Journal of Psychiatry 157(2): 281-283
Baer, F.M.; Theissen, P.; Crnac, J.; Schmidt, M.; Jochims, M.; Schicha, H. 1999: MRi assessment of coronary artery disease. Rays 24(1): 46-59
De Cobelli, F.; Cappio, S.; Vanzulli, A.; Del Maschio, A. 1999: MRi assessment of coronary stents. Rays 24(1): 140-148
Baer, F.M.; Theissen, P.; Schneider, C.A.; Kettering, K.; Voth, E.; Sechtem, U.; Schicha, H. 1999: MRI assessment of myocardial viability: comparison with other imaging techniques. Rays 24(1): 96-108
Corballis, P.M.; Inati, S.; Funnell, M.G.; Grafton, S.T.; Gazzaniga, M.S. 2001: MRI assessment of spared fibers following callosotomy: A second look. Neurology 57(7): 1345-1346
Natale, L.; Meduri, A.; Caltavuturo, C.; Palladino, F.; Marano, P. 2001: MRi assessment of ventricular function. Rays 26(1): 35-44
Dimitrova, A.; Weber, J.; Redies, C.; Kindsvater, K.; Maschke, M.; Kolb, F.P.; Forsting, M.; Diener, H.C.; Timmann, D. 2002: MRI atlas of the human cerebellar nuclei. NeuroImage 17(1): 240-255
Tang, H.; Wu, E.X.; Ma, Q.Y.; Gallagher, D.; Perera, G.M.; Zhuang, T. 2000: MRI brain image segmentation by multi-resolution edge detection and region selection. Computerized Medical Imaging and Graphics: the Official Journal of the Computerized Medical Imaging Society 24(6): 349-357
Maguire, A.M.; Ogden, J.A. 2002: MRI brain scan analyses and neuropsychological profiles of nine patients with persisting unilateral neglect. Neuropsychologia 40(7): 879-887
Gasperini, C.; Paolillo, A.; Giugni, E.; Galgani, S.; Bagnato, F.; Mainero, C.; Onesti, E.; Bastianello, S.; Pozzilli, C. 2002: MRi brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a. Multiple Sclerosis 8(2): 119-123
Wu, E.X.; Towe, C.W.; Tang, H. 2002: MRi cardiac tagging using a sinc-modulated RF pulse train. Magnetic Resonance in Medicine 48(2): 389-393
Schmidt, R.; Schmidt, H.; Fazekas, F.; Kapeller, P.; Roob, G.; Lechner, A.; Kostner, G.M.; Hartung, H.P. 2000: MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study. Arteriosclerosis Thrombosis and Vascular Biology 20(7): 1811-1816
Petrén-Mallmin, M.; Linder, J. 1999: MRI cervical spine findings in asymptomatic fighter pilots. Aviation Space and Environmental Medicine 70(12): 1183-1188
Leadbetter, R.A.; Shutty, M.S.; Elkashef, A.M.; Kirch, D.G.; Spraggins, T.; Cail, W.S.; Wu, H.; Bilder, R.M.; Lieberman, J.A.; Wyatt, R.J. 1999: MRI changes during water loading in patients with polydipsia and intermittent hyponatremia. American Journal of Psychiatry 156(6): 958-960
Puri, B.K.; Bydder, G.M.; Chaudhuri, K.R.; Al Saffar, B.Y.; Curati, W.L.; White, S.J.; Mitchell, L.; Hajnal, J.V.; Horrobin, D.F. 2001: MRi changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine. Neuroreport 12(9): 1821-1824
Küker, W.; Weise, J.; Krapf, H.; Schmidt, F.; Friese, S.; Bähr, M. 2002: MRI characteristics of acute and subacute brainstem and thalamic infarctions: Value of T2- and diffusion-weighted sequences. Journal of Neurology 249(1): 33-42
Frohman, E.M.; Zhang, H.; Kramer, P.D.; Fleckenstein, J.; Hawker, K.; Racke, M.K.; Frohman, T.C. 2001: MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis. Neurology 57(5): 762-768
Ni, Y.; Adzamli, K.; Miao, Y.; Cresens, E.; Yu, J.; Periasamy, M.P.; Adams, M.D.; Marchal, G. 2001: MRI contrast enhancement of necrosis by MP-2269 and gadophrin-2 in a rat model of liver infarction. Investigative Radiology 36(2): 97-103
Cotton, F.; Weiner, H.L.; Jolesz, F.A.; Guttmann, C.R.G. 2003: MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 60(4): 640-646
Howard, A.K.; Li, D.K.B.; Oger, Jël. 2003: MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 30(1): 41-48
Rovaris, M.; Filippi, M. 2000: MRI correlates of cognitive dysfunction in multiple sclerosis patients. Journal of Neurovirology 6(Suppl): S172-S175
Pohjasvaara, T.; Mäntylä, R.; Salonen, O.; Aronen, H.J.; Ylikoski, R.; Hietanen, M.; Kaste, M.; Erkinjuntti, T. 2000: MRI correlates of dementia after first clinical ischemic stroke. Journal of the Neurological Sciences 181(1-2): 111-117
Ahearn, E.P.; Jamison, K.R.; Steffens, D.C.; Cassidy, F.; Provenzale, J.M.; Lehman, A.; Weisler, R.H.; Carroll, B.J.; Krishnan, K.R. 2001: MRI correlates of suicide attempt history in unipolar depression. Biological Psychiatry 50(4): 266-270
Dhenain, M.; Michot, J.L.; Privat, N.; Picq, J.L.; Boller, F.; Duyckaerts, C.; Volk, A. 2000: MRI description of cerebral atrophy in mouse lemur primates. Neurobiology of Aging 21(1): 81-88
Grabill, C.; Silva, A.C.; Smith, S.S.; Koretsky, A.P.; Rouault, T.A. 2003: MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice. Brain Research 971(1): 95-106
Greenberg, S.M.; O'Donnell, H.C.; Schaefer, P.W.; Kraft, E. 1999: MRi detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology 53(5): 1135-1138
Held, P.; Seitz, J.; Fründ, R.; Nitz, W.R.; Haffke, T.; Hees, H.; Bonkowsky, V. 2000: MRI detection of olfactory bulb and tract. Journal of Neuroradiology 27(2): 112-118
Saeki, N.; Uchida, D.; Tatsuno, I.; Saito, Y.; Yamaura, A. 1999: MRi detection of suprasellar germinoma causing central diabetes insipidus. Endocrine Journal 46(2): 263-267
Vykhodtseva, N.; Sorrentino, V.; Jolesz, F.A.; Bronson, R.T.; Hynynen, K. 2000: MRI detection of the thermal effects of focused ultrasound on the brain. Ultrasound in Medicine and Biology 26(5): 871-880